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131  Summary
Glutamate is found throughout the central nervous system and has been shown to be an 
important excitatory neurotransmitter in the visual system.
There are two subdivisions of receptor on which this ubiquitous neurotransmitter acts, 
metabotropic (mGluR) and ionotropic (GluR) glutamate receptors.  There are eight sub- 
types of mGluR falling into three groups, and fifteen GluR subunits also divided into three 
groups.  Kainate receptors (KARs) comprise one group of the ionotropic glutamate receptor 
subdivision.
Relay cells of the lateral geniculate nucleus (LGN) are driven and modulated by a variety 
of NMDA, AMPA and metabotropic receptors.  In addition, investigation into the 
involvement of mGluR, AMPA and NMDA receptor function in the synaptic processing of 
the superior colliculus (SC) has been well documented.  It has been difficult, however, to 
establish specific KAR function in these brain structures due to lack of pharmacological 
agents acting solely at kainate receptors.  In recent years such agents have become 
available, thus enabling the present study of GluR5 involvement in visual processing within 
the SC and LGN.
The purpose of this body of work has been to assess the involvement of GluR5-containing 
Kainate receptors (KARs) in synaptic transmission between retinal ganglion cells (RGCs) 
and subcortical brain structures involved in the processing of visual information; namely
14the superficial superior colliculus (SSC) and the lateral geniculate nucleus (LGN).  The 
majority of the work focused on the function of KARs in the SSC.
To elucidate the involvement of KARs in visual processing, both in vivo and in vitro 
methods were utilised.  In vivo electrophysiology was used for extracellular recording of 
evoked activity of both SSC and LGN neurons in response to visual stimuli.  This was 
carried out during intravenous injection of GluR5 antagonist.  In vivo recording twinned 
with iontophoretic administration of GluR5-specific pharmacological compounds was also 
employed to investigate KAR participation in direct synaptic transmission between RGCs 
and the SSC neurons.  The same technique was used to study KAR involvement in the 
phenomenon of response habituation exhibited by these neurons.
To parallel in vivo protocols, in vitro SSC slice experiments were performed to study the 
effect of GluR5 agonists and antagonists on evoked postsynaptic currents.  This enabled the 
administration of drugs at concentrations specific for GluR5 subunits whilst investigating 
GluR5 involvement in direct synaptic transmission between RGC input and SSC neurons.
In addition, a paired pulse protocol was employed to propose a presynaptic location of 
GluR5-containing KARs at retinal input into the SSC.  Furthermore, the use of GluR5- 
specific and GABAR-specific compounds during evoked current recording indicated the 
involvement of GluR5-containing receptors in the direct modulation of excitatory but not 
inhibitory input into the SSC.
15In summary, therefore, both in vivo and in vitro electrophysiology techniques were used to 
indicate a location and function for GluR5 KARs in the subcortical visual system of the rat.
GluR5-containing receptors were found to modulate visual processing of both the LGN and 
SSC.  It was unclear whether these receptors were located in the LGN itself due to the use 
of systemic injection protocols, however, iontophoresis of GluR5-selective drugs 
demonstrated a role in modulating visual responses within the SSC.  The mechanism by 
which GluR5 receptors modulated responses in the SSC was further elucidated by a series 
of whole cell patch-clamp experiments which revealed that GluR5-containing receptors 
reduced synaptic transmission at excitatory inputs directly onto recorded cells and those 
connections with the intrinsic inhibitory circuitry of the SSC.  In addition a paired-pulse 
protocol was used to determine that the decrease in excitatory transmission was caused by 
the presynaptic reduction of glutamatergic transmission.
162  Glutamate Receptors
The status of glutamate as a neurotransmitter was initially uncertain as this amino acid is 
also involved in intermediary metabolism within the brain, including protein synthesis, as a 
precursor of y-aminobutyric acid (GABA) and in the detoxification of ammonia.  However, 
it is now known glutamate exerts a powerful stimulatory effect on neuronal activity via its 
actions upon specific receptors.
Glutamate is now considered the most ubiquitous excitatory neurotransmitter in the 
mammalian central nervous system (CNS), and is stored in synaptic vesicles of nerve 
terminals until its release into the synaptic cleft.  This is mediated by a Ca2+-dependent 
exocytotic process upon depolarisation of the terminal (Cooper et al.,  1996).
The receptors which are concerned with glutamatergic synaptic transmission can be 
classified into two families, the metabotropic glutamate receptors (mGluRs) and the 
ionotropic glutamate receptors (GluRs).
2.1  Metabotropic Glutamate Receptors
The mGluRs are G-protein-coupled receptors (GPCRs) which can be further subdivided 
into eight subtypes which, based on sequence homology, coupling to second messenger 
systems and pharmacology, fall into three groups (Nakanishi,  1992; Conn & Pin,  1997). 
Group I, mGluR 1   and mGluR5, and their splice variants, mGluR la, b and c (Pin et al., 
1992) and mGluR5a and b (Minakami et al.,  1993; Joly et al.,  1995; Yamaguchi and 
Nakanishi,  1998), are coupled to post-synaptic phosphoinositide metabolism (Aramori and
17Nakanishi,  1992; Abe et al.,  1992).  Group II receptors (mGluR2 and mGluR3) and Group 
III receptors (mGluR4a and 4b, mGluR6, 7a and 7b, and 8a and 8b) both appear to down- 
regulate cyclic AMP (cAMP) metabolism in expression systems (Conn & Pin,  1997). 
Within each group mGluRs share 70% homology, but only 45% sequence homology is 
shared between the groups (Conn & Pin,  1997).
Group I mGluRs are involved in phosphoinositide (PI) hydrolysis via phospholipase C 
(PLC) which results in a rise in intracellular Ca2+ (Aramori & Nakanishi,  1992; Abe et al.,
1992).  However, Group I receptors have been observed to stimulate an increase in cAMP 
and arachadonic acid in some preparations (Anwyl,  1999; Fagni et al., 2000), while 
mGluR 1   is able to potentiate NMDA currents via a G-protein-independent mechanism 
linked to Src kinase activation in hippocampal CA3 neurons (Heuss and Gerber, 2000). 
Furthermore, mGluR la and mGluR5 are believed to function via a G-protein-independent 
mechanism with direct interaction with the protein Homer, resulting in raised intracellular 
Ca24 (Brakeman et a!.,  1997).  Additional differences between the two Group I subtypes 
include the observation that mGluR 1   action is blocked to a greater extent than mGluR5 
when exposed to pertussis toxin (PTX), although the action of mGluR la is only partially 
PTX sensitive while mGluR lb is PTX-insensitive (Conn & Pin,  1997).
Group II and III mGluRs are able to inhibit forskolin-induced cAMP production (Conn & 
Pin,  1997). Thus their action is to inhibit adenylyl cyclase (AC) activity, which in turn 
inhibits cAMP formation (Conn & Pin,  1997).  Group II and III mGluRs are all PTX- 
sensitive and therefore likely to be coupled to Gj-proteins (Conn & Pin,  1997).Glutamate 
binding domain
Cysteine rich 
domain
7-TM domain 
G-protein bindingQ
Carboxyl
terminal
Figure 1. Putative structure of mGluR 1   subunit  taken from Conn and Pinn,  1997.  The 
structure  consists  of  a  7  transmembrane  domain  protein  with  a  glutamate  binding 
domain,  cysteine  rich  domain  and  G-protein  coupling  segment  on  the  second 
intracellular loop, and a cytoplasmic carboxyl terminal.2.1.1  Structure
Metabotropic glutamate receptors consist of a large N-terminal, 7 transmembrane domains 
and a C-terminal region.  From the structure of mGluR 1   (figure  1), it has been proposed 
that the N-terminal is located extracellularly and the C-terminal is situated intracellularly, 
due to N-glycosylation sites and putative C-domain phosphorylation sites (Masu et al., 
1991).  In addition, the extracellular location of 19 conserved cysteine residues suggests 
that these are of functional importance. The N-terminal is suggested to be the location of 
glutamate binding and agonist selectivity sites, based on chimeric receptor research 
(Takahashi et al.,  1993).
C-terminal deletions affecting agonist potency suggest a role for this terminal  is possibly 
the regulation of the associated transduction mechanism (Flor et al.,  1996). G-protein 
activation is proposed to be via the first and third intracellular loops as amino acid sequence 
is highly conserved throughout the mGluRs. Less well conserved regions located on the 
mGluR 1   receptor are thought to mediate specific interaction of this receptor with 
phospholipase C (Pin et al.,  1994).
2.1.2  Pharmacology
Glutamate analogues such as ACPD (l-amino-cyclopentane-l,3-dicarboxylate) and L-AP4 
(L-2-amino-4-phosphonobutyrate) are specific for mGluRs, but potencies differ between 
subtypes.  Group I mGluRs demonstrate the agonist potency series: Quisqualate > 3,5- 
DHPG (dihydroxyphenylglycine) > Glutamate > Ibotenate = ACPD (Conn & Pin,  1997).
20Along with the potent agonist 3,5-DHPG, the less potent agonist, 3-HPG (3- 
hydroxyphenylglycine) is specific for Group I, while t-ADA (/r<ms-azetidine-2, 4- 
dicarboxylate) and CHPG (carboxyhydroxyphenylglycine) are more selective mGlu5 
agonists (Conn & Pin,  1997).
The phenylglycine derivatives (S)-4-carboxy-phenyl-glycine ((S)-4CPG) and (S)-4C3HPG 
are relatively potent, specific mGluR la competitive antagonists (Kingston et al.,  1995), 
however, these also act on Group II receptors at higher concentrations (Hayashi et al., 
1994).  More specific antagonists include a compound based on (S)-4CPG, LY367385, 
which is selective for mGlul, and MPEP (2-methyl-6-(phenylethynyl)pyridine) selective 
for mGlu5 (Gasparini et al.,  1999).
Selective Group II agonists include DCG-IV ((2S,  10R, 20R, 30R)-2-(2, 3- 
dicarboxycyclopropyl)glycine) and L-CCG-I ((2S,  l ’S, 2’S)-2-
(carboxycyclopropyl)glycine. However, DCG-IV is also an NMDA agonist (Hayashi et al.,
1993), and L-CCG-I is active at mGluR 1   and mGluR4 at higher concentrations (Hayashi et 
al.,  1992).  Group II antagonists include MCCG (a-methyl-L-CCG-I) and phenylglycine 
derivatives MPPG (a-methyl-4-phosphonophenylglycine), MSPG (a-methyl-4- 
sulfonophenylglycine) and MTPG (a-methyl-4-tetrazoylphenylglycine), although MCCG is 
more potent and specific (Flor et al.,  1996).  Both Group I and II mGluRs are sensitive to 
the antagonist LY393053, a compound related to the phenylglycines (Salt et al.,  1999;
Chen et al., 2000; Kingston et al., 2002).
21Among the glutamate receptors, Group III alone shows sensitivity to the agonists L-AP4 
and L-SOP (L-serine-O-phosphate). (S)-3,4-DCPG ((S)-3,4-Dicarboxyphenylglycine) is a 
potent selective mGlu8 agonist (Thomas et al., 2001)  (Conn & Pin,  1997; Ozawa et al., 
1998; Schoepp et al.,  1999).  Antagonists for Group III mGluRs include the phenylglycine 
derivative CPPG ((RS)-a-cyclopropyl-4-phosphonophenylglycine) (Bedingfield et al.,
1996; Toms et al.,  1996).  MAP4 and MSOP, a-methyl derivatives of agonists L-AP4 and 
L-SOP respectively, are selective competitive antagonists of Group III receptors, but both 
display some agonist effect at mGluR2 (Gomeza et al.,  1996; Thomas et al,  1996).
2.1.3  Physiology
Activation of Group I mGluRs is thought to cause the reduction of K+ leak currents and 
voltage-dependent K+  currents, resulting in a slow depolarisation of the membrane potential 
(Charpak et al.,  1990). Along with this depolarisation an increased action potential firing 
rate has been observed in hippocampal, neocortical and cerebellar neurons. This is possibly 
due to the inhibition of after-hyperpolarisation via a Ca2+ dependent K+  current (Charpak et 
al.,  1990).  Observation of slow repolarisation in hippocampal neurons supports this idea 
(Hu & Storm,  1991).  MGluRs also activate Ca2+-dependent and independent non-specific 
cation currents, a Na+/Ca2+ ion exchanger and possibly a Ca2+-activated K+ current (Conn 
& Pin,  1997;Pin & Duvoisin,  1995).  All three groups of metabotropic glutamate receptor 
are implicated in the inhibition of voltage-dependent Ca2+ channels (VDCCs) in vitro, but 
the receptors involved vary between different brain regions (Pin & Duvoisin,  1995).
22In the SC the Group I agonist, DHPG, leads to the reduction of evoked EPSP/Cs and action 
potentials via mGluRl  (White et al., 2003).  The inhibition appears to be phospholipase 
C/protein kinase C independent and independent of Ca2+ release from internal stores, and is 
not caused by an increase in GABAergic transmission.  Instead it is suggested that 
inhibition occurs directly via the activation of an autoreceptor at excitatory terminals 
(White et al., 2003).  It is also revealed that DHPG activity is not via the inhibition of N- 
type VDCC, however, N-type VDCC inhibition is shown to be mediated by ACPD in CA3 
pyramidal neurons (Swartz & Bean,  1992).  Alternatively, other groups have shown ACPD 
administration to result in the inhibition of voltage-dependent K+-channels in cultured, 
hippocampal, pyramidal neurons (Wu and Barish,  1999).
PTX-sensitive Group II and III receptors are able to inhibit L-type Ca2+ channels which can 
also be inhibited by a Group I-linked Ca2+ dependent, protein kinase-independent pathway. 
N-type Ca2+ channel inhibition is also observed. Again, neuron-specific receptor types 
mediate this activity and reduction of N- and L-type currents does not occur in all instances, 
and has even been seen to be elevated in some cell types (Conn & Pin,  1997; Pin & 
Duvoisin,  1995).
Group I mGluRs are also involved in GABAa receptor inhibition and AMPA receptor 
current potentiation in the nucleus of the solitary tract. Group I receptors can also potentiate 
NMDA and AMPA receptor actions in the spinal cord and potentiate NMDA currents in 
pyramidal cells (Pin & Duvoisin,  1995).
232.1.3.a  Synaptic Plasticity
High frequency stimulation of input can result in a sustained increase in excitability of the 
postsynaptic cell termed long-term potentiation (LTP).  Conversely the cumulative 
activation of input can also reduce postsynaptic excitability which causes long-term 
depression (LTD).  These are both forms of synaptic plasticity in which glutamate receptors 
are thought to play an important role.
Metabotropic glutamate autoreceptors are concerned with the reduction of glutamatergic 
neurotransmission and have some involvement in synaptic plasticity. The Group III agonist, 
L-AP4 reduces glutamatergic transmission, while Group II receptors reduce both inhibitory 
and excitatory transmission, probably via the reduction of Ca2+ currents (Ozawa et al., 
1998). It is unclear whether mGluRs are involved in CA1  LTP, and if so, how they may be 
involved. Mutation of mGluRl  has also given contradictory results regarding the receptor 
involvement in NMDA-independent mossy fibre-LTP, however LTD via mGluR2 at this 
synapse has been observed.  MGluR2 is also implicated in olfactory LTP, possibly due to 
the inhibition of GABAergic transmission at granule cell dendrites (Ozawa et al,  1998).
The potentiation of NMDA receptor activity and excitatory transmission via Group I 
receptors results in neurotoxic glutamate release and cell death. Conversely, Group II and 
possibly Group III receptors are involved in presynaptic inhibition of glutamate release 
which has a neuroprotective action (Pin & Duvoisin,  1995).
242.2  Ionotropic Glutamate Receptors
Ionotropic glutamate receptors are ligand-gated ion channels, and can be subdivided into 3 
groups based upon their agonist pharmacology; N-methyl-D-aspartate (NMDA), a-amino- 
3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) and kainate (KA) receptors 
(Ozawa etal.,  1998;Nakanishi,  1992;Watkins & Evans,  1981).  However, kainate receptors 
(KARs) containing KA2/GluR6 subunit assemblies produce a non-desensitising current to 
AMPA  (Herb et al.,  1992;Sakimura et al,  1992) and AMPA receptors (AMPARs) to 
kainate (Seeburg,  1993), therefore, these two groups have been historically termed non- 
NMDA receptors.
The AMPAR subunit GluRl  and the NMDAR subunit NR1  were identified by molecular 
cloning and expression in Xenopus oocytes (Hollmann et al.,  1989;Moriyoshi et al.,  1991). 
Further cloning and PCR techniques led to the elucidation of additional receptor subunits. 
To date, four AMPA receptor subunits (GluRl-GluR4), five kainate receptor subunits 
(GluR5-GluR7, KA1  and KA2) and six NMDA receptor subunits, NR1, NR2A-D and 
NR3A  (also known as NR-like and x-1  (Ciabarra et al.,  1995)) and NR3B (Chatterton et 
al., 2002) have been demonstrated (Ozawa et al.,  1998). Additional variants of these 
subunits can be formed due to alternative splicing and RNA editing.
All ionotropic glutamate receptors possess an extracellular N-terminus domain and an 
intracellular C-terminal domain. Between these terminals can be found three 
transmembrane domains (TMI, TMIII and TM IV) and a region of the protein which either 
resides in the intracellular leaflet of the plasma membrane or forms a hairpin turn within the
25membrane (Mil) (figure 2) (Bennett & Dingledine,  1995;Hirai et al.,  1996;Z.Galen Wo and 
Robert E.Oswald,  1995).
2.3  NMDA receptors
2.3.1  Structure
Structurally, 40-50% sequence homology is displayed between NR2 subtypes.  25-29% 
homology is shown between NR1  and other iGluRs, but only -18% homology between 
NR1  and NR2 subtypes (Hollmann & Heinemann,  1994).  NR1  can form functional 
homomeric assemblies but with smaller conductance than native NMDARs. This indicates 
that native receptors are heteromeric assemblies (Moriyoshi et al.,  1991).  NR2A-D have 
also been cloned but must be coexpressed with NR1  subunits to form functional receptor 
channels (Mori & Mishina,  1995).
NMDAR subunits coassemble into an oligomeric arrangement containing an NR1  subunit 
and various NR2 subunits which show differential distributions throughout the brain 
(Monyer et al.,  1992).  The assemblies produce NMDARs possessing a polyamine 
modulatory site, Zn2+ binding site and modulation sites for reducing agents and protons 
(Gozlan & Ben Ari,  1995).
2.3.2  Distribution
Ligand binding studies have localised NMDARs throughout the brain with highest levels 
present in the hippocampal CA1  region (Monaghan et al,  1989).  Distribution of different
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Figure  2.  GluR2  structure  taken  from  Ozawa et  al.,  1998.  The protein  consists  of a 
large  extracellular  N-terminal,  three  transmembrane  domains  (TMI-III),  a  domain 
residing within the membrane, and an intracellular C-terminal.  The boxed area shows 
the region targeted for ‘flip’ or ‘flop’ alternative splicing.subunits is subject to developmental changes in the rodent.  These include a postnatal 
alteration from NR2B and NR2D to NR2A and NR2C (Monyer et al.,  1994). 
Developmental differences may be explained by different functional properties of the 
subunits (Mg2+ block, deactivation kinetics).  In addition, the distribution of the NR3A 
subtype changes with maturation (Ciabarra et al.,  1995) while NR3B is found mainly in 
motor neurons (Chatterton et al., 2002).
2.3.3  Ion channel properties
NMDA receptors mediate excitatory neurotransmission, however, these receptors display 
slow channel kinetics.  This is due to a voltage-dependent Mg2+ block which is released as 
the membrane potential increases (Ascher & Nowak,  1988;MacDermott et al.,  1986;Mayer 
et al.,  1984;Nowak et al.,  1984).
High Ca2+ permeability and some degree of the Mg2+ block of the NMDAR channel is 
conveyed by an asparagine residue at the position corresponding to a glutamine/arginine 
site in non-NMDAR subunits (Hollmann & Heinemann,  1994;Mori & Mishina, 
1995;Seeburg,  1993).  The asparagine residue also affects the channel diameter in NR1- 
NR2A and B assemblies which is the reason suggested for the lower divalent cation 
conductance of these assemblies (Ozawa et al.,  1998).  NMDARs are also Na+, K+ and Cs+ 
permeable (Ozawa et al.,  1998).
282.3.4  Pharmacology
The NMDAR agonist binding site appears to involve amino acid residues preceding TMI 
and between TMIII and IV on NR2 subunits (Laube et al,  1997). The same residues of the 
NR1  subunit however, appear to affect glycine binding (Hirai et al,  1996).  Glycine 
binding is important as it is necessary as a coagonist for NMDAR channel activation 
(Ozawa et al.,  1998) D-serine, however, has been shown to be active at the glycine binding 
site in concentrations found normally in rodent frontal cortex (Matsui et al.,  1995). 
Compounds acting at this binding site along with the glutamate binding site, sites within the 
ion channel and the various modulatory sites can modify NMDAR activity (Sucher et al., 
1996).
Competitive antagonists for NMDARs include D-AP5 (D-2-amino-5- 
phosphonopentanoate), a more potent derivative of the early NMDAR blocker, D-a- 
aminoadipate binds at NMDARs with the following potencies: NR1/NR2A>B>C>D (Mori 
& Mishina,  1995).  Another competitive antagonist for the glycine binding site, 7-CL- 
Kynurenate (7-CK), also shows differential binding; NR1/NR2C>B>A=D (Bleakman & 
Lodge,  1998).  The non-competitive antagonists PCP and ketamine, however, block 
NMDA channels and have similar effects on all NR2 subunits (Mori & Mishina,  1995). 
Other intrachannel blockers include Zn2+, Mg2+ and MK-801, a structurally related 
compound to PCP, but displaying greater potency and selectivity (Mori & Mishina,  1995).
NMDAR activity can be modulated by alteration in proton, zinc and Ca2+ concentrations.  A 
voltage-dependent reduction of NMDA-evoked current can be achieved by the addition of
29protons. IC50 values for proton inhibition occur at around physiological pH (6.9-7.3) 
suggesting native NMDARs are tonically inhibited and may serve as a physiological pH 
sensor (Kumamoto,  1997).  NMDAR activity is also inhibited by low concentrations of 
zinc, depending on NR1  splice variants, but its inhibition is voltage dependent at higher 
concentrations (Yamakura & Shimoji,  1999).  In addition, increases in intracellular Ca2 +  
([Ca2+]j) cause the dissociation of an actin filament-associated regulatory protein leading to 
inactivation of the NMDAR, which may be a possible protective mechanism during 
ischaemia.  Furthermore, calmodulin binds to NR1  when [Ca2+]j is increased, leading to 
inactivation of NMDAR (Yamakura & Shimoji,  1999).
2.3.5  Physiology
During synaptic transmission, NMDARs generate a slowly activating current further 
characterised by a decay at least  100-fold slower than that of AMPARs.  The receptor 
affinity for glutamate and response decay time are, however, influenced by the subunit 
arrangement (Cull-Candy et al., 2001).
2.3.5.a  Synaptic Plasticity
NMDARs are implicated in the cellular basis of memory and learning due to their ability to 
induce long term potentiation (LTP).  Tetanic stimulation of hippocampal CA1  neurons 
causes a larger, long-lasting depolarisation which removes Mg24 blockade. Ca2+ influx 
follows, which may further increase [Ca2+], by calcium-induced calcium release from 
internal stores and lead to the induction of intracellular signalling cascades (Mori & 
Mishina,  1995).  Blockade of this effect by MK-801, 7-CK or AP5 indicates that NMDAR
30action as well as membrane depolarisation are crucial for the occurrence of LTP (Bliss & 
Collingridge,  1993).  Further evidence for NMDA involvement in learning and memory is 
that AP5 antagonism and NR1  mutation reduces spatial learning in rats (Davis et al.,
1992;Sakimura et al.,  1995).
2.3.5.b  Developmental Plasticity
Involvement of NMDAR channels in developmental plasticity has been demonstrated by 
chronic AP5 block of kitten visual cortex (Kleinschmidt et al.,  1987) and studies of the 
visual development of dark-reared rats (Binns & Salt,  1998).  The NR1  subunit is 
implicated in such plasticity following mutation studies of the NR-1  subunit (Li et al., 
1994;Mori & Mishina,  1995).
2.3.5.C  Neuronal Cell Death
Application of NMDAR antagonists provide protection against glutamate neurotoxicity 
(Olney,  1990).  In vitro evidence also demonstrates the prevention of NR1  subunit 
formation reduces NMDA-evoked neurotoxicity in vitro and ischaemic damage in vivo 
(Wahlestedt et al.,  1993).
2.4  AMPA receptors
2.4.1  Structure
The oligomeric assemblies formed from GluRl-GluR4 can consist of a homomeric or 
heteromeric arrangement of subunits (Ozawa et al.,  1998).  It is the subunit configuration of
31the receptor assembly which leads to pharmacological and functional differences (Ozawa et 
al.,  1998).
Alternative splicing in all AMPA subunits imparts two versions of a 38 amino acid 
sequence preceding the fourth transmembrane domain of the receptor, giving AMPA 
receptors either a ‘flip’ or ‘flop’ configuration (Sommer et al.,  1990).  This confers 
different pharmacological and kinetic properties to the receptor such as sensitivity to L- 
glutamate.
2.4.2  Distribution
On a gross level, [3H]AMPA-binding studies have revealed large amounts of high affinity 
AMPA receptors in the hippocampus, especially CA1, CA3 and pyramidal cell layers, 
dentate gyrus and superficial cerebral cortex (Monaghan et al.,  1984;01sen et al.,  1987). 
Lower levels are found deeper in the cortex and caudate-putamen. Even smaller levels have 
been localised in the diencephalon, midbrain and brainstem (Ozawa et al.,  1998).  All 
receptor subunit mRNA levels are low in the thalamus, although GluR4 mRNA is the most 
abundant in the reticular thalamic nucleus (RTN) (Keinanen et al.,  1990).
Specific antibody binding studies have revealed GluRl, 2/3, and 4 subunits on the plasma 
membrane of the cell body and dendrites (mainly postsynaptic locations), the outer 
mitochondrial and nuclear membranes and on microtubules (Petralia & Wenthold,  1992). 
GluRl  and 2/3 are located at postsynaptic positions in the dendrites and the dendritic spines 
after initial embryonic distribution throughout the neurons (Craig et al.,  1993).  The
32alternatively spliced ‘flip’ subunit configuration can be mainly found in embryonic 
neurons, while the ‘flop’ sequence receptor expression increases globally from postnatal 
day 8 to day  14 when most AMPA receptor assemblies consist o f‘flop’ subunits (Monyer 
et al.,  1991;Sommer et al.,  1990).
2.4.3  Ion channel properties
Homomeric assemblies of the GluRl, 3 and 4 subunits are inwardly rectifying and 
permeable to N a\ K+ and Ca2+, whereas GluR2 assemblies rectify outwardly and show 
little permeability to Ca2+ (Ozawa et al.,  1998).  Furthermore, heteromeric assemblies 
containing GluR2 subunits display properties associated with this subunit, ie. outward 
rectification and Ca2+ impermeability (Hollmann & Heinemann,  1994;Seeburg,  1993). 
Differences in rectification and permeability are due to a single positively charged arginine 
residue in GluR2 subunits which during RNA editing replaces a neutral glutamine residue 
present in other subunits (Seeburg,  1993).  The edited version of GluR2 is prevalent 
postnatally, however, embryonic AMPAR subunits display a small amount of unedited 
GluR2 subunits (Seeburg,  1993).  Thus the presence of GluR2 determines Ca2+ 
permeability of AMPA receptors.
2.4.4  Kinetics
Segments SI and SII preceding TMI and TMIV appear to form an extracellular agonist 
binding site (Stem-Bach et al.,  1994). Once bound, AMPA (Trussed et al.,  1988), 
quisqualate (Tang et al.,  1989), glutamate (Trussed et al.,  1988) and to some extent, kainate
33(Kiskin et al.,  1986), produce rapidly desensitising currents.  These desensitisation rates 
vary with subunit configuration (Mosbacher et al.,  1994); desensitisation after activation is 
slower in edited receptor subunit assemblies than unedited arrangements (Lomeli et al.,
1994).  AMPA receptors also display relatively rapid deactivation rates which increase as 
desensitisation rate increases (Geiger et al.,  1995).
2.4.5  Physiology
As the kinetics suggest AMPA receptors mediate fast synaptic transmission at most central 
synapses. Receptor activation and therefore EPSC kinetics are regulated by glutamate 
concentration in the synaptic cleft and receptor subunit configuration. The subunit 
arrangement is crucial in determining receptor affinity, desensitisation, and maybe more 
importantly, deactivation (Ozawa et al.,  1998).
Low Ca2+ permeability is conferred by the GluR2 subunit, however, central synapses have 
been identified which have Ca2+ permeable AMPA receptors. This seems to depend on the 
number of GluR2 subunits within the assembly. The permeability may indicate an AMPA 
receptor-mediated, Ca2+-dependent long-term modulation in these neurons (Gu et al.,  1996; 
Jia et al,  1996).
342.5  Kainate Receptors
2.5.1  Structure
KARs are thought to be tetrameric structures (Lerma et al., 2001) comprised of five 
different subunits, low kainate affinitiy subunits GluR5, 6 and 7, and high affinity subunits 
KA1  and KA2 (Hollmann & Heinemann,  1994).  Each subunit consists of approximately 
900 amino acids which are thought to share membrane topology similar to that of other 
ionotropic glutamate receptors (Wo & Oswald,  1995).
These subunits were first identified using cloning techniques based on sequence homology 
for AMPARs (GluR 1  -4) (Bettler et al.,  1990; Egebjerg et al.,  1991; Bettler et al.,  1992 ; 
Morita et al.,  1992; Sommer et al.,  1992).  KARs share only 40% homology with AMPARs 
and about 20% homology with NMDARs (Hollmann & Heinemann,  1994, Lerma et al., 
2001).  Within the KAR group itself low affinity subunits share approximately 75% 
homology, whilst KA1  and KA2 appear to display 68% sequence homology, although the 
two groups are believed to share only 45% homology with each other (Chittajallu et al.,
1999).
Of the KAR subunits GluR5, 6 and 7 can form functional homomeric ion channels in 
expression systems (Bettler et al.,  1990; Egebjerg et al.,  1991; Sommer et al.,  1992;
Schiffer et a!.,  1997) while KA1  and KA2 are unable to form functional channels on their 
own (Werner et al.,  1991; Herb et al.,  1992) but KA2 may assemble with the low affinity 
GluR5 or 6 subunits to form functional heteromeric channels (Herb et al.,  1992; Sakimura
35et a/.,  1992).  Additionally, GluR5, 6 and 7 are able to assemble to form functional 
heteromeric channels (Bortolotto et al.,  1999; Cui and Mayer,  1999; Patemain et al., 2000).
GluR5 has two splice variants, GluR5-l  and GluR5-2, with GluR5-l  having a  15 amino 
acid addition to the extracellular N terminal (Bettler et al.,  1990).  GluR5-2 possesses 
additional variants (a, b and c) with differing C terminal domains (Sommer et al.,  1992). 
Alternative C terminal splice variants have also been reported for GluR7 (GluR7a and 
GluR7b) (Schiffer et al.,  1997).  In addition, a human splice variant of GluR5 (GluR5-ld) 
has been identified, along with a splice variant of the mouse GluR6 subunit (GluR6-2). 
Both produce differences in the C-terminal domain (Gregor et al.,  1993).
Thus it is feasible that KARs can consist of a number of receptor subunit combinations.
2.5.2  Distribution
The first proposal for a new receptor group, KARs, was suggested after studies showed 
DRG fibres depolarised when exposed to KA (Davies et a!.,  1979;Agrawal and Evans, 
1986).  It was observed that KA blocked C-fibre action potential conduction (Agrawal and 
Evans,  1986), which was later validated by patch clamp experiments (Huettner,  1990; 
Wong and Mayer,  1993; Lee et al., 2001).  Molecular biology has since revealed genes 
encoding KAR subunits and the existence of splice variants and post-transcriptional 
modification (Chittajallu et al.,  1999).  In particular the expression of GluR5 and GluR6 
subunits has been demonstrated in dorsal root ganglion (DRG) and spinal neurons 
(Kerchner et al., 2002).
36Both high and low affinity kainate binding sites exist throughout the CNS, especially in the 
CA3 region of the hippocampus and cerebellar granule cells (Roche & Huganir,  1995; 
Siegel et al.,  1995;Ozawa et al.,  1998).  GluR5 mRNA can be identified in the neocortex, 
especially the cingulate and piriform cortex, and to some extent in CA1  pyramidal neurons, 
in the striatum and in some septal nuclei (Wisden & Seeburg,  1993).  Within the thalamus 
GluR5 mRNA is expressed in the anteroventral nucleus and in subdivisions of 
unidentifiable thalamic nuclei (Wisden & Seeburg,  1993) while GluR6 and KA1  are seen at 
low levels throughout the thalamus.  The reticular nucleus appears to contain high levels of 
GluR7 mRNA (Bettler et al.,  1992; Monyer et al.,  1992; Wisden & Seeburg,  1993) with 
weak expression of GluR6 and KA2 (Wisden & Seeburg,  1993).  All kainate subunit 
mRNA is expressed diffusely throughout the SC, however, a laminar expression of GluR5 
mRNA can be seen in the intermediate grey layer (Wisden & Seeburg,  1993).
In situ hybridisation for GluR5, 6, 7 and KA2 has shown these subunits to be expressed 
throughout the CNS, for example, in the cortex, striatum, hippocampus and cerebellum.  In 
contrast, KA1  is expressed in hippocampal CA3 and dentate granule cells (Bettler et al.,
1990; Egebjerg et al.,  1991; Werner et al.,  1991; Lomeli et al.,  1992; Wisden and Seeburg,
1993; Bahn et a!.,  1994; Tolle et al.,  1993; Partenain et al., 2000; Bureau et al.,  1999).
GluR5-7 subunits have been identified in hippocampal dendrites (Siegel et al,  1995), 
whereas GluR6/7 and KA2 receptor subunits have been found post-synaptically in small 
spine synapses of the stratum oriens, CA1/CA2 and CA3 molecular layers (Petralia et al., 
1994). Both GluR6/7 and KA2 immunostaining was also observed post-synaptically in
37mossy fibre synapses of the CA3 layer (Petralia et al.,  1994).  Petralia et al., (1994) also 
suggest that staining can be observed presynaptically in unmyelinated axons.
2.5.3  Ion Channel Properties
Due to the larger EPSP formation of AMPAR activity, a large proportion of kainate 
receptor channel research has been performed in recombinant expression systems.
These have revealed that homomeric GluR5 or 6 receptors can produce rapidly 
desensitising kainate-evoked currents, whereas homomeric GluR7, KA 1   and KA2 receptor 
assemblies appear functionless.
Higher kainate binding affinities of KA1  and KA2 (Herb et al.,  1992; Sakimura et al., 
1992), have led to the proposed idea that heteromeric assemblies in native tissue containing 
these subunits may form higher affinity receptors than those lacking them (Contractor et 
al., 2003).  This does not in fact occur; GluR5/KA2 heteromers appear to have lower 
affinity for kainate binding than either KA2 or GluR5 homomers (Herb et al.,  1992).
Rapid desensitisation to agonist application is characteristic of KARs (Lerma et al., 2001) 
the rate of which is both subunit and cell type dependent (Lerma et al., 2001 ;Patemain et 
a!.,  1998).  Recovery is also dependent on agonist (Lerma et al., 2001) and subunit 
composition (Swanson et al.,  1998); the presence of the KA2 subunit in the arrangement 
reduces receptor affinity for the ligand (Swanson et al.,  1996) and therefore may confer a 
faster recovery.
38As with the AMPAR subunit GluR2, the KAR subunits GluR5 and 6 may also undergo 
post-transcriptional editing (Sommer et al.,  1991).  Once again editing results in the 
alteration of a glutamine (Q) residue to a positively charged arginine (R) residue in the Mil 
pore-forming region of the subunit (Chittajallu et al.,  1999).  Unedited forms of these 
subunits display strong inward rectification propeties (Herb et al.,  1992;Sommer et al.,
1992), however, edited homomeric GluR5 and GluR6 receptors (Egebjerg et al.,  1991) and 
GluR5/KA2 or GluR6/KA2 assemblies (Herb et al.,  1992) show a linear or slight outward 
rectification.  In addition, editing confers a reduction of Ca2+-permeability to homomeric 
GluR5 and 6 (Bumashev et al.,  1995; Egebjerg & Heinemann,  1993).  Homomeric 
assemblies comprised of both edited and unedited forms of the GluR5 and 6 subunit also 
demonstrate either a linear or outward rectification along with reduced Ca2+ permeability 
(Sommer et al.,  1992;Egebjerg & Heinemann,  1993;Kohler et al.,  1993; Bumashev et al.,
1996).  Furthermore, the presence of any unedited versions in the assembly will confer 
impermeability to Cf ions (Bemashev et al.,  1996).  The edited ion channel properties 
appear to remain applicable for embryonic hippocampal cultures in addition to the 
recombinant expression systems in which they were characterized (Ruano et al.,  1995).
2.S.4  Metabotropic signalling pathways
In addition to the ion channel properties, KARs may also exert effects via G-protein 
signalling pathways.  To date this has been shown to occur in the hippocampus (Roriguez- 
Moreno and Lerma,  1998; Frerking et al., 2001; Cunha et al., 2000; Melyan et al., 2002) 
and cultured dorsal root ganglion neurons (Rozas et al., 2003).  In dorsal root ganglia the 
activation of GluR5-containing KARs have been implicated in the Gj/G0-dependent release
39of Ca2+ from intracellular stores resulting in PKC-mediated inhibition of N-type Ca2+- 
channels (Frerking et al., 2001; Rozas et al., 2003).  In addition, a metabotropic effect has 
been suggested to underlie the KAR-modulation of a postsynaptic K+-current which 
mediates the slow afterhyperpolarisation in CA1  pyramidal neurons (Melyan et al., 2002). 
This metabotropic activity, mediated by GluR5 and in some cases possibly GluR6 and KA2 
(Melyan et al., 2004; Fisahn et al., 2005), may be due to an intermediate/linker protein 
between the ion channel subunit and a target G-protein (Coussen et al., 2005).
2.5.5  Physiology
Physiological functions of KARs include the contribution to EPSC/P after glutamate 
release and the presynaptic modulation of synaptic transmission by the reduction of 
transmitter release.
2.5.5.a  Effect on excitatory transmission
Among the numerous proposed roles of KARs, they have been found to act presynaptically 
at excitatory synapses to modulate glutamate release.
At mossy fibre-CA3 synapses EPSPs and EPSCs are reduced by the administration of KA 
(Kamiya and Ozawa, 2000).  This effect can also be achieved by endogenous transmitter 
release upon associational commissural fibre stimulation presumably by the activation of 
presynaptic KARs (Schmitz et al., 2000).
40It is the GluR5 subunit that has been implicated in the modulation of presynaptic mossy 
fibre and associational/commissural transmission onto CA3 neurons, and also (Vignes et 
a!.,  1998; Lauri et al., 2001a; 2001b), although GluR6 and GluR5'VGlurb A  mice show an 
absence of KAR-mediated inhibition of input to CA3 neurons, whereas GluR5'' respond as 
wildtype (Chittajallu et al.,  1996; Kamiya and Ozawa,  1998) suggesting that it is the GluR6 
subunit and not the GluR5 subunit that is required to modulate input onto CA3 neurons. 
Explanations for these anomalies include the proposals that heteromeric KARs are 
expressed at MF synapses which respond to GluR5 selective drugs, homomeric GluR5 
KARs are not expressed in GluR6  ' animals (Huettner, 2001; Lauri et al., 2003), or they do 
not form functional assemblies (Sommer et al.,  1992).
It is suggested that GluR5 reduces mossy fibre transmission indirectly by increasing 
intemeuron firing which activates presynaptic GABAbRs (Schmitz et al., 2000).  However, 
this block of tert-butyl AMPA (ATPA) effect by GABAb antagonists has not been observed 
by other groups and results have been interpreted as the ability of GluR5 to directly 
modulate mossy fibre transmission or by indirectly affecting GABA transmission or 
transmission of other neurotransmitters (Lauri et al., 2001b).
At synapses between Schaffer collaterals and CA1  neurons, presynaptic KARs are able to 
reduce glutamatergic transmission (Chittajallu et al.,  1996) which have been linked to 
reduced presynatpic Ca2+ transients (Kamiya and Ozawa,  1998).  However, KAR acitivity 
at this synapse appears to have a bidirectional influence on the modulation of excitatory 
transmission; the administration of high KA concentration (l-30pM) causes an initial 
increase in spontaneous EPSCs followed by a reduction in evoked EPSCs at Schaffer
41collateral-CAl  synapses, whilst low KA concentration (300nM) produces a small increase 
in evoked EPSCs (Chittajallu et al.,  1996).  The GluR5 subunit has again been associated 
with the modulation of transmission at Schaffer collateral/commissural input at CA1 
pyramidal neurons (Vignes et al.,  1998).
As at the Schaffer collateral-CAl  synapse, the activation of KARs in lamina II of the dorsal 
horn results in the increase in sEPSCs (Lee et al.,  1999), but the reduction of evoked DRG- 
dorsal horn transmission (Kerchner et al., 2001a).  An increase in spontaneous 
transmission, coupled to the reduction of evoked transmission could both be a result of the 
activation of KARs. This activation could result in a rise in intracellular Ca2+ causing 
transmitter release which may be followed by receptor desensitisation, or reduced release 
by subsequent activation of intemeurons and GABA release.
Although previous studies have excluded non-NMDARs from a role in LTP induction 
(Castillo et a!.,  1994;Ito & Sugiyama,  1991), additional research has produced results 
consistent with an involvement of GluR5 activation in mossy fibre-CA3 LTP induction 
(Bortolotto et al.,  1999; Lauri et al., 2001 a;Ji and Staubli, 2002).  It is possible that 
plasticity at this synapse may be either via the modulation of presynaptic excitatory input or 
due to a postsynaptic alteration, although knockout studies appear to suggest that the GluR5 
subunit is not an absolute requirement for this at mossy fibre or associational/commissural 
synapses (Contractor et al., 2000).
42In the immature animal (P3-P5) it is the GluR5 subunit which modulates transmission at 
thalamocortical synapses during high frequency stimulation, suggesting a possible role in 
mediating frequency-dependent depression of synaptic transmission (Kidd et al., 2002).  In 
addition, this role of GluR5-mediated frequency-dependent depression was not observed in 
animals aged P7-8 which indicates a possible role in developing neuronal networks (Kidd 
et al., 2002).
2.5.5.b  Effect on inhibitory transmission
The reduction of miniature inhibitory postsynaptic potentials (mIPSPs) by application of 
kainate has been demonstrated by some (Lerma et al., 2001), while other groups have not 
observed these results (Ben Ari & Cossart, 2000;Frerking & Nicoll, 2000), therefore their 
involvement in the reduction of inhibition remains unclear.
A role of KARs in the reduction of evoked inhibitory transmission has been demonstrated 
in hippocampal CA1  (Clarke et al.,  1997;Min et al.,  1999;Rodriguez-Moreno et al.,  1997) 
and CA2/CA3 neurons (Fisher and Alger,  1984; Kehl et al.,  1984).  It is possible that this 
may indicate the involvlement of KARs in the disinhibition of network activity.
Conversely, however, the activation of KARs has also been implicated in an increase in 
spontaneous firing of intemeurons (Cossart et al.,  1998;Frerking et al.,  1998;Semyanov & 
Kullmann, 2001).  Furthermore, both facilitation and depression of GABAergic synaptic 
transmission has been observed depending on the concentration of kainate applied (Braga et 
al., 2003;Jiang et al., 2001).  This bidirectional modulation of GABA release, however, 
does not occur with differing concentration at intemeuron-intemeuron synapses.  Both high
43(Mulle et al., 2000) and low (Cossart et al., 2001) kainate concentrations increase 
inhibitory transmission at these synapses.
It has been demonstrated that the application of kainic acid and the endogenous release of 
glutamate are able to increase hippocampal intemeuron firing (Ben Ari & Cossart, 
2000;Frerking & Nicoll, 2000;Semyanov & Kullmann, 2001).  KA administration increases 
action potential firing in intemeurons in the CA1  region (Cossart et al.,  1998; Frerking et 
al.,  1998), possibly via GluR5 (Cossart et al.,  1998; Mulle et al., 2000).  This effect on 
intemeurons was suggested to be mediated by somatodendritic KARs (Frerking et al.,
1998; Cossart et al.,  1998), although a subsequent study indicated an axonal location was 
more probable (Semyanov and Kullmann, 2001).
In addition to studies of KARs in the hippocampus, projection neurons in the striatum 
possess the GluR6 subunit which appears to reduce GABAergic transmission indirectly 
apparently via adenosine A2A receptor activation (Chergui et al., 2000).  KARs may also 
be located both pre- and postsynaptically in the hypothalamus with the presynaptic KARs 
regulating inhibitory transmission (Liu et al.,  1999).
There are further instances illustrating the role of KARs in the depression of GABAergic 
transmission onto neurons of the hippocampal region (Rodriguez-Moreno et al., 
1997;Rodriguez-Moreno & Lerma,  1998). This was suggested to be caused by an increase 
of extracellular GABA concentration which can desensitise postsynaptic GABAa receptors 
(Benardo,  1993;Overstreet et a!., 2000) and activate presynaptic GABAb receptors
44(Frerking et al.,  1999;Kerchner et al., 2001).  However, the reduction of evoked IPSCs 
(elPSCs) in CA1  was not reversed by a GABAbR antagonist (Clarke et al.,  1997), and 
furthermore, there is evidence that the endogenous release of glutamate by excitatory input 
appears to reduce elPSCs by activating presynaptic KARs on the GABAergic terminals 
themselves (Min et al.,  1999).
Functional presynaptic KARs have also been observed at GABAergic intemeuron synapses 
with pyramidal cells in layer V of the motor cortex of the rat.  Here the activation of GluR5 
leads to a presynaptic reduction of GABAergic transmission (Ali et al., 2001).  Additional 
observations in dentate granule neurons have shown that KA increases sIPSC frequency 
and decreases elPSC amplitude via the activation of presynaptic KARs (Behr et al., 2002).
Prolonged kainate application directly increases the amplitude of afferent volleys and 
antidromic action potentials in mossy fibre axons, which can be reversed by co-application 
of the quinoxalinedione CNQX.  These results were also obtained in response to synaptic 
glutamate release (Schmitz et al., 2000).  Schmitz et al. (2000) also demonstrated that 
synaptic transmission can be inhibited by the activation of presynaptic KARs at mossy fibre 
terminals with low concentrations of kainate (0.1-0.2 pM) or endogenous glutamate, 
however, KA administration directly increased afferent volley amplitude.  The same 
depression of synaptic transmission was seen using ATPA although without affecting 
afferent volleys.  Additional experiments suggest the effects of ATPA were via GABA 
release onto presynaptic GABAb receptors.  These results are supported by the observation 
that low concentration of kainate (250 nM) increased mIPSC frequency in CA1
45intemeurons, although this was not mediated via a GluR5-containing receptor assembly 
(Cossart et al., 2001)
A presynaptic mechanism of modulation has also been hypothesized for synaptic 
transmission in the reticular nucleus (RTN) of the thalamus.  However, no evidence for 
presynaptic KAR activity or location has been observed at synapses from either the ventral 
posterior nucleus (VP) or layer VI collaterals from the barrel cortex (Bolea et al., 2001).  In 
contrast kainate autoreceptors mediate an afterdepolarisation in mossy fibre synapses, thus 
allowing subsequent axonal stimulation to cause a presynaptic facilitation of Ca2+ influx. 
Therefore, KA autoreceptors are believed to be involved in short-term synaptic plasticity at 
mossy fibre-CA3 synapses (Kamiya et al., 2002).
Presynaptic KAR activation may also increase inhibitory transmission from intemeurons of 
the dorsal horn, possibly by the enhancement of Ca2+ entry into the cell due to membrane 
depolarisation (Kerchner et al., 2001b).  This may lead to increased GABA release and 
activation of GABA autoreceptors resulting in the reduction of evoked IPSCs at these 
synapses (Kerchner et al., 2001b).
Reports of presynaptic KARs at granule cell input onto stellate cells in the cerebellum, 
which enhance transmission by activation with low concentration of domoate (5nM) or low 
frequency stimulation (10-20Hz) but which reduce transmission when higher 
concentrations of agonist (10-500nM) or high frequency stimulation (100Hz) are 
administered (Delaney & Jahr, 2002).  Interestingly, the activation of presynaptic KARs at
46parallel fibre/granule cell input onto Purkinje cells produced an enhancement of 
transmission at stimulation frequencies of up to  100Hz and agonist concentrations up to 
50nM (Delaney & Jahr, 2002).  Reduction of transmission was only observed at higher 
concentrations of domoate (500nM) (Delaney & Jahr, 2002).
Presynaptic GluR5 may also be involved in the regulation of inhibitory transmission onto 
pyramidal neurons of the basolateral amygdale (BLA) (Braga et al., 2003); low doses of 
GluR5 agonist increase mIPSC frequency, but higher concentrations reduce the frequency 
of these events.  Furthermore, GluR5 antagonist reduces elPSC amplitude indicating tonic 
activation of these receptors, which results in the increase of inhibitory transmission in this 
brain region.
In summary the literature reflects a versatile role of KARs in the modulation at presynaptic 
terminals of excitatory and inhibitory inputs into a variety of brain structures.  KARs have 
been reported to reduce excitatory transmission in the DRG and at thalamocortical 
synapses.  A reduction is also observed in the hippocampus which is reported to be as a 
result of GluR5 activation.
Alternatively reduced inhibitory transmission is described in the striatum and motor cortex, 
however, increased inhibitory transmission is observed in the RTN and dorsal horn 
intemeurons.  Increase inhibitory transmission is also seen in the BLA which is possibly 
caused by GluR5 activation.
47KARs are also able to cause the reduction of both excitatory and inhibitory transmission in 
the same brain region ie. the hippocampus.  Finally, KARs are able to both increase and 
reduce inhibitory transmission at the same neurons in the hippocampus, cerebellum and the 
basolateral amygdala via a bidirectional modulation.
2.5.5.C  Postsynaptic Kainate Receptors
KARs produce slow EPSCs of small amplitude compared to that of AMPA (Swanson et al., 
1996) and are easily ignored during recording (Kidd & Isaac,  1999).  However, KARs are 
able to drive intemeuron spikes due to large EPSC formation (Cossart et al.,  1998). The 
slow decay found in CA3 neurons is most probably frequency facilitation caused by mossy 
fibres or a possible presynaptic affect of KARs (Vignes & Collingridge,  1997).
Repetitive stimulation of hippocampal mossy fibres causes the activation of a slow 
excitatory current in CA3 neurons (Castillo et al.,  1997;Vignes & Collingridge,  1997).  The 
use of pharmacological agents shows that the activity is consistent with the postsynaptic 
localisation of KARs on CA3 dendrites (Castillo et al.,  1997).  Subsequent work 
demonstrated that the GluR5 subunit did not mediate these postsynaptic events, but a 
presynaptic GluR5 receptor assembly was involved in the modulation of transmission 
(Lauri et al., 2001a).  These conclusions were drawn because the GluR5-selective 
antagonist, LY382884, did not affect the amplitude of the first mossy fibre EPSC but 
significantly reduced subsequent EPSCs evoked at  100 Hz.
48Although postsynaptic KAR-mediated currents are detectable in CA1  pyramidal neurons, 
postsynaptic KARs do not appear to mediate excitatory transmission in this region 
(Chittajallu et al.,  1996).  Instead, these postsynaptic KARs appear to modulate a slow 
afterhyperpolarisation (sAHP) by the inhibition of a K+ current via a GluR5 independent, 
metabotropic KAR component (Melyan et al., 2002).
In addition, synaptic transmission in the basolateral amygdala produced by stimulation of 
the external capsule is mediated in part by GluR5-containing KARs (Li & Rogawski,
1998).  Here it is thought that GluR5 receptors may have a role in high frequency (50Hz) 
facilitation and low frequency (1 Hz) EPSP enhancement (Li and Rogawski,  1998; Li et al., 
2001).  There is also possible postsynaptic involvement in nociceptive and thermoreceptive 
afferent transmission in spinal cord (Li et al.,  1999).
Both KARs and AMPARs have been implicated in postsynaptic transmission between cone 
photoreceptors and subtypes of bipolar cell in the retina of the ground squirrel (DeVries, 
2000). GluR5-containing KARs are found to mediate transmission between cone 
photoreceptors and b3 and b7 off-bipolar cells (DeVries & Schwartz,  1999; DeVries 2000). 
The differential activation of these non-NMDA receptor types may lead to temporal 
processing due to the differences in desensitisation recovery rates of the receptor 
assemblies.
Slower rise time and decay components of KAR-mediated postsynaptic events may indicate 
a role in temporal integration of excitatory input (Frerking & Ohliger-Frerking, 2002).
49Anatomical studies have lead to the idea that differences in KAR-mediated action are due 
to subunit localisation.  GluR6 expression has been localised in pyramidal cells mediating 
excitatory transmission, while GluR5 has been located mainly in inhibitory intemeurons 
(Bureau et al,  1999).
Thalamocortical synapses exhibit EPSCs which are mediated by AMPARs or KARs only, 
however, some of these connections are mediated by both AMPAR and KAR components 
(Kidd & Isaac,  1999).  It appears a developmental progression results in the replacement of 
KARs with AMPARs as mediators of postsynaptic events (Kidd and Isaac,  1999).
Although KARs are not found in abundance in the spinal cord (Tolle et al.,  1993; Petralia et 
al.,  1994), electrophysiological studies have revealed postsynaptic KAR function in layer II 
of the dorsal horn, possibly at A5 and C-fibre input (Li et al.,  1999).  Here, trains of stimuli 
decreased KAR-mediated EPSCs, however, a reduction due to KAR desensitisation cannot 
be ruled out (Li et al.,  1999).
A role for GluR6 has been suggested at cerebellar Golgi neurons (intemeurons) 
postsynaptic to parallel fibre input (Bureau et al., 2000).  GluR5 and GluR6 have been 
located on these neurons while GluR7, KA1  and KA2 are not found here (Bureau et al., 
2000).
These observations indicate that KARs indeed have a postsynaptic role in synaptic 
transmission in the hippocampus, BLA and spinal cord.  Additional reports indicate that
50postsynaptic KARs have a developmental role in thalamocortical synapses.  GluR5 and 
GluR6 in particular are thought to be involved in postsynaptic events at cone synapses on 
bipolar neurons and at cerebellar Golgi neurons respectively.
2.5.6  AMPAR and KAR Pharmacology
2.5.6.a  Agonists
KAR subunits make up functional homomeric and heteromeric ion channels which are 
found throughout the CNS, and can be co-expressed with AMPARs  (Frerking & Nicoll,
2000).  This caused difficulty in distinguishing between the receptor types for some time 
until the development of specific pharmacological agents i.e. the AMPAR-selective 
antagonists, 2,3-benzodiazepines (Wilding & Huettner,  1995).
Kainate and domoate are both KAR agonists although these compounds activate non­
desensitising responses in AMPAR assemblies.  In addition, tert-butyl AMPA (ATPA), 
although originally developed as an AMPA receptor agonist, is highly selective for GluR5 
receptor assemblies (Clarke et al.,  1997).
SYM2081  and LY339434 demonstrate weak activity at AMPA receptors and also to some 
extent at NMDA and mGluRs (Brauner-Osbome et al.,  1997;Small et a!.,  1998). However, 
SYM2081  displays  100-1000 fold selectivity for KARs over AMPARs.  It is also used as a 
functional antagonist due to rapid desensitisation kinetics at KARs (Clarke et al.,  1997).
Halogenated derivatives of willardiine have recently been synthesized which display 
specificity for AMPA or kainate receptors. (S)-5-fluorowillardiine is AMPA selective,
51while (S)-5-iodowillardine (Wong et al.,  1994) and 5-iodo-6-willardiine (Jane et al.,  1997) 
show greater KAR selectivity (Jane et al.,  1997). Homomeric GluR7, KA1  and KA2 
receptors seem unresponsive to agonists, although this may be because of fast 
desensitisation of the receptor complex (Lerma et al., 2001).
2.5.6.b  Competitive Antagonists
The quinoxalinediones CNQX and DNQX are potent non-NMDA competitive antagonists. 
More selective is NBQX which antagonises AMPARs with a 30 times smaller 
concentration than is needed to affect KARs (Sheardown et al.,  1990).
Decahydroisoquinolines LY382884, LY294486 and LY293558 have displayed higher 
antagonist activity at GluR5 kainate receptors than AMPA receptors (Bleakman et al.,
1996)  but no activity at GluR6 kainate receptors (Clarke et al.,  1997;Vignes et al.,  1997).
2.5.6.C  Non-competitve Antagonists
2,3-benzodiazepines (GYKI52466, LY300168 (GYKI53655) and GYK153784 
(LY303070)) are non-competitive AMPA receptor antagonists (Ruel et al., 2002). These 
compounds are more selective for AMPARs than KARs (Ruel et al., 2002). Another non­
competitive antagonist, SYM2206 is thought to act at the same site as the 2,3- 
benzodiazepines (Pelletier et al.,  1996).
2.5.6.d  Modulators
Modulators can act on AMPA receptors to reduce agonist desensitisation of the receptor.
52Pyrrolidones (eg: aniracetam and piracetam), benzothiadiazides (eg: cyclothiazide and 
diazoxide) and  1-BCP, a compound related to pyrrolidones, fall into this category 
(Bleakman & Lodge,  1998).  PEPA (Sekiguchi et al.,  1997) and SI89866 (a pyrolo- 
benzothiadiazide derivative) (Desos et al.,  1996) have also been reported to positively 
affect desensitisation while thiocyanate ions seem to enhance receptor desensitisation 
(Bowie & Smart,  1993).
Other modulators include Evans Blue which reduces AMPAR activation (GluR2 and 4), 
and Joro spider toxin (JSTX) which blocks GluRl, 3 and 4 AMPA receptors with high 
affinity but has no effect at edited GluR2 receptors (Fletcher & Lodge,  1996).
AMPAR and KAR responses to kainate and quisqualate are both potentiated by Zn2+.  Cd2+ 
causes a similar increase in kainate and quisqualate responses while La3+ enhances kainate 
responses via AMPARs and KARs by elevating channel affinity for agonists (Kumamoto,
1997).  A specific KAR modulator is the lectin, Concanavalin A (Ozawa et al.,  1998).
More recent AMPAR modulators include CX516 (BDP-12) which increases the amplitude 
of the response (Arai et al., 2002).  In addition, CX546 appears to lower the rate of receptor 
deactivation thus increasing response duration (Arai et al., 2002).  Both of these 
compounds are benzamide-type agents.
533  GABA Receptors
y-aminobutyric acid (GABA) is the most widely distributed inhibitory neurotransmitter in 
the vertebrate CNS (Sivilotti & Mistri,  1991).  GABA is found at high concentrations 
throughout the mammalian CNS (pM/g) (Cooper et al,  1996).  Currently three classes of 
GABAR have been identified, the ionotropic channels GABAa and GABAc, and the 
metabotropic GABAb receptors (Bormann, 2000).
3.1  Structure and Receptor Properties
GABAa and GABAc recptors form channels permeable to CI/HCO3   (Johnston,  1996; Enz 
and Cutting,  1998; Chebib and Johnston,  1999; Bormann 2000).  GABAaRs are pentameric 
structures composed of subunits belonging to six families (a 1-6, (31-4, y 1-4, 8, e, 0) 
(Bonnert et al.,  1999; Hevers & Luddens,  1998; Mohler et al.,  1996; Bormann, 2000).
Each receptor is believed to be comprised of at least  la  and  1(3 subunit (Hevers & Luddens,
1998).  GABAcRs are also believed to be pentameric structures, comprised of rho (p) 
subunits, of which there are three types p 1   - p3 (Cutting et al.,  1991; Enz & Cutting,  1998; 
Shingai et al.,  1996).  In comparison to GABAaRs, GABAcRs produce currents of smaller 
amplitude and slower activation (Bomann 2000; Boiler & Schmidt, 2003).
Cloning studies have revealed two GABAbRs subunits, R1  and R2, of which two 
GABAbRI  splice variants have also been identified (Rla and Rib) (Bettler et al.,  1998; 
Kaupmann et al.,  1997).  These receptor subunits appear to share structural similarities with 
mGluRs (Kaupmann et al.,  1997).  Functional GABAbRs are heterodimeric, comprising
54GABAbRI  and GABAbR2 subunits (Jones et al.,  1998; White et al.,  1998; Kaupmann et 
al.,  1998; Marshall et al.,  1999).
GABAbRs are coupled presynaptically to Ca2+ channels and postsynaptically to inwardly 
rectifying K+  channels (Couve et al., 2000; Mott & Lewis,  1994) to mediate slow synaptic 
inhibition in the CNS (Kerr & Ong,  1995).
3.2  Distribution
Autoradiography and Immunohistochemistry have shown GABAbRs to be expressed in 
abundance throughout the CNS, especially in the cerebellum (Kerr & Ong,  1995).
GABAcRs are expressed in the vertebrate retina (Lukasiewiscz,  1996; Matthews et al., 
1994; Enz et al.,  1995; Matsui et al., 2001; McCall et al., 2002; Qian & Ripps, 2001). In 
this location, postsynaptic GABAcRs mediate inhibitory input at the amacrine-giant bipolar 
cell synapse (Lukasiewiscz & Shields,  1998; Matsui et al., 2001).
These receptors have also been located in other discrete areas of the brain (Boue-Grabot et 
al.,  1998; Enz and Cutting,  1999; Wegelius et al.,  1998).  Bicuculline- and baclofen- 
resistant GABA effects have been observed in cerebellum (Drew & Johnston,  1992), 
amygdala (Delaney & Sah,  1999), dLGN (Zhu & Lo,  1999) and SC (Boiler & Schmidt,
2001; Schmidt et al., 2001; Edwards et al., 2002).  Furthermore, in situ hybridisation shows 
that the p-subunit is highly expressed in subcortical visual structures, including the SC,
55pretectal nuclear complex (PNC) and dLGN (Boue-Grabot et al.,  1998; Bom & Schmidt, 
2004; Wegelius et al.,  1998).
3.3  Physiology
GABA is the major transmitter in a wide range of inhibitory intemeurons including basket 
cells of the cerebellum and hippocampus, Purkinje cells of the cerebellum, granule cells of 
the olfactory bulb and amacrine cells of the retina (Schwartz, 2000).  GABAergic neurons 
are involved in the modulation of network activity throughout the brain therefore an 
alteration in GABAergic transmission is able to modify network behaviour.  Such changes 
in GABA release can be observed to modify synaptic plasticity in the hippocampus 
(Wigstrom & Gustafsson,  1983) and contribute to epileptiform activity in models of 
temporal lobe epilepsy (Hirsch et al.,  1999).
The pi-subunit has been colocalised with synaptophysin (Clark et al., 2001) suggesting that 
GABAcRs may play a role in synaptic transmission.
3.4  Pharmacology
The GABAaR has modulatory binding sites for benzodiazepines, barbiturates, 
neurosteroids and ethanol (Bormann,  1988; Macdonald & Olsen,  1994), although 
benzodiazepine-insensitive forms of the GABAaR occur with the subunit arrangement of 
cx|38 or ape termed GABAa o (Barnard et al.,  1998).  Among the most commonly used 
selective compounds for GABAaRs is the agonist muscimol (Macdonald & Olsen,  1994), 
and the competitive antagonist bicuculline (Curtis et al.,  1970).
56Like GABAaRs, GABAcRs can be activated by GABA, but at concentrations  10 times 
lower than those necessary to activate GABAaRs (Johnston,  1996; Bormann & Feigenspan, 
1995; Feigenspan & Bormann,  1998; Polenzani et al.,  1991).  GABAcRs do not respond to 
either bicuculline or baclofen (Johnston,  1996; Bormann & Feigenspan,  1995), however, 
the GABA analogue m-4-aminocrotonic acid (CACA) is active as a selective GABAc 
agonist (Johnston,  1996).  Antagonists to GABAcRs include the GABAa/GABAcR C P  
channel blocker, picrotoxin (Feigenspan & Bormann,  1998; Cutting et al.,  1991) and the 
more selective GABAcR antagonist TPMPA ((l,2,5,6-tetrahydropyridine-4-yl) 
methylphosphinic acid) (Ragozzino et al.,  1996; Chebib et al.,  1997).
GABAbRs can be activated by the selective agonist, baclofen (Seabrook et al.,  1990) which 
appears to have no activity at either GABAaRs or GABAcRs (Kusama et a!.,  1993; Kerr & 
Ong,  1995; Woodward et al.,  1993).  Antagonists for the GABAbR include CGP35348 
(Olpe et al.,  1990) and CGP55845A (Davies et al.,  1993).
574  The Rat Visual System
The visual system of the rat is typical of nocturnal rodents, and is broadly similar to that of 
most mammals.  Light entering the eye is detected by the photoreceptors of the retina.  This 
visual information is transmitted via the optic nerve to subcortical structures for processing 
before being relayed to cortical regions.
4.1  Retina
Like that of most rodents, the rat retina predominantly contains rod photoreceptors, with 
cones accounting for around just 0.85% of photoreceptors. The majority of cones (93%) 
contain a long-wavelength sensitive photopigment (maximum sensitivity 500-520 nm), the 
remainder (7%) possess an ultraviolet-sensitive pigment (maximum sensitivity ~370 nm) 
(Deegan & Jacobs,  1993).
Signals from the photoreceptors are transmitted to retinal ganglion cells (RGCs) via three 
types of intemeuron, the bipolar, horizontal and amacrine cells (Tessier-Lavigne, 2000). 
These neurons combine signals from a number of neighbouring photoreceptor inputs to 
initiate visual processing at the level of the retina (Tessier-Lavigne, 2000).
The rat retina contains around  110,000 ganglion cells (Perry et al.,  1983).  The distribution 
of these neurons varies across the retina with highest densities (approximately 3000 
cells/mm2) being found in the area centralis, and lower densities (approximately 600 
cells/mm2) in the peripheral retina (Sun et al., 2002).  The dendritic trees and thus receptive 
fields of ganglion cells in the area centralis are no different from those of peripheral cells,
58suggesting that objects of interest are not brought into focus on a region of high resolution 
(Huxlin & Goodchild,  1997).
The ganglion cells projecting exclusively to the SC possess smaller somata than those 
projecting to the dLGN, although some cells project to both nuclei (Moriya & Yamadori,
1993).  Approximately 6% of the ganglion cells projecting to the SC mediate GABAergic 
neurotransmission (Caruso et a/.,  1989) suggesting that there is some direct inhibitory 
transmission from the retina.
4.2  Retinal Output
The optic nerve arises from axons of the retinal ganglion cells, which project through the 
optic chiasm to relay information via the optic nerve to the visual areas of the brain.  Whilst 
almost all ganglion cells project to the SC (Linden & Perry,  1983a), axon branching occurs 
in fast conducting and large ganglion cells allowing these neurons to innervate both the 
contralateral dLGN and SC (Kondo et al.,  1993).
Of the ganglion cell projections only approximately 3% form an ipsilateral projection to 
target nuclei which provides a binocular representation of the visual field (Jeffery,  1984).
4.3  Primary Visual Nuclei
The mammalian visual system operates as a series of parallel pathways, with retinal 
projections to the dorsal lateral geniculate nucleus (dLGN), superior colliculus (SC),
59ventral lateral geniculate nucleus (vLGN), intergeniculate leaflet (IGL), pretectum and 
accessory optic nuclei (Sefton et al., 2004).
The dorsal lateral geniculate nucleus (dLGN) relays information from the retina to the 
visual cortex.  The major input to the rat dLGN arises from the contralateral eye, although a 
region of ipsilateral input does exist (Lund et al.,  1974).  The rat dLGN lacks lamination, 
although regional variations have been suggested (Reese,  1988).  Different regions of the 
dLGN appear to be innervated by different morphological classes of ganglion cell (Martin,
1986).  The retina is mapped topographically in the rat dLGN (Sefton et al., 2004). 
Projections from the dLGN are to the ipsilateral visual cortex and visual thalamic reticular 
nucleus (Rt) (Sefton et al., 2004). Rt is involved in focal attention mechanisms, with 
damage to this nucleus resulting in deficits in orienting tasks (Guillery et al.,  1998; Weese 
et al.,  1999).  The dLGN is described in more detail in chapter 5.
Virtually all retinal ganglion cells of the rat project to the superior colliculus (SC) (Linden 
and Perry,  1983).  The superficial grey and upper optic strata receive retinal inputs, and in 
turn project to regions including the intermediate and deep layers of the SC (Harting et al., 
1973).  Complex circuits link the multimodal intermediate and deep SC layers to areas 
associated with the selection of appropriate motor responses to novel stimuli.  These 
include the cerebellum, substantia nigra and basal ganglia (Niemi-Junkola & Westby,  1998,
2000).  Axons arising from the contralateral eye provide the primary input to the upper 
layers of the SC (Toga & Collins,  1981), with ipsilateral retinal input to only the rostral SC 
(Martin et al.,  1983).  Like most vertebrates, this projection is topographically organised
60(Siminoff et al.,  1966), although in the rat the central visual field is not magnified 
compared with the periphery (Siminoff et al.,  1966; Toga & Collins,  1981).
The function of the SC is to locate biologically significant stimuli within the visual field, 
rather than to identify the stimulus (Sefton et al., 2004).  The localisation of stimuli by the 
SC leads to behavioural responses including the orientation of head, eyes or ears towards 
visual stimuli and the initiation of avoidance, defense or escape behaviours (see Sefton et 
al., 2004 for more information).  The SC is described in more detail in chapter 6.
4.4  Visual Cortex
Seven visuotopically organised areas are found in the rat occipital cortex (for review see 
Van Essen,  1979), the largest of these being the primary visual cortex (variously termed 
area O cl, area  17, striate cortex, area VI).
The projection neurons from the primary visual cortex (pyramidal and some spinous stellate 
cells) use glutamate and/or aspartate as excitatory transmitters.  Glutamatergic neurons are 
primarily found in layers 2 and 3, and aspartatergic neurons are found in layers 2-6 (Fosse 
& Fonnum,  1987; Johnson & Burkhalter,  1992).  Nonpyramidal cells account for around 
15% of the entire neuronal population of the primary visual cortex, and are thought to be 
GABAergic (Lin et a/.,  1986; Ribak et al.,  1978).
The primary visual cortex of the rat is a granular cortex with 6 layers. The majority of 
dLGN fibres terminate in layer 4 and lower layer 3 (although some reach layers  1   and 6).
61Layer 6 of the primary visual cortex projects to the dLGN (Sefton et la., 2004).The primary 
neurotransmitter of these fibres may be excitatory amino acids, such as glutamate and 
aspartate (Johnson and Burkhalter,  1992;Fosse et al.,  1984).
625  The Lateral Geniculate Nucleus
The dorsal lateral geniculate nucleus (dLGN) is part of the dorsal thalamus in the 
diencephalon.  In the cat the LGN is a laminated structure receiving input from the retina 
via three functionally distinct cell types, W, X and Y, which correspond to koniocellular, 
parvocellular and magnocellular pathways in primate (Sherman & Guillery, 2002).  This 
type of lamination is not seen in the rat although the nucleus appears to be segregated into 
an inner core of cells with a Y cell-like function, and an outer shell of cells, receiving 
collicular and retinal input, which may serve a W cell-like function (Reese,  1988).
Ascending input includes that from RGCs, lower brain centres such as the cerebellum and 
mammillary bodies or from higher order layer V cortical neurons (Sherman & Guillery, 
1996).
The thalamus passes on information via relay cells to primary sensory areas of the cortex 
and other cortical areas such as the motor and cingulate cortex (Sherman & Guillery, 2002), 
and receives reciprocal projections from each area of the cortex it projects to (Crick,  1984). 
As well as being modulated by these reciprocal projections, relay cell activity is modulated 
by inhibitory input from the visual area of the reticular nucleus (part of the ventral 
thalamus) and neurons of the perigeniculate nucleus (Sherman & Guillery,  1996).
Thalamic neurons exhibit two different patterns of response to excitatory input, burst or 
tonic firing.  This is influenced by T-type Ca2+ channels located on both soma and
63dendrites, known as I t, which are voltage- and time-dependent (Destexhe et al.,  1998;Zhou 
etal.,  1997).
Burst firing occurs when It is activated.  The current causes an influx of Ca2+ and 
subsequent membrane depolarisation in the form of a low threshold calcium spike (LTS) 
which leads to a burst of action potentials.  However, when the membrane depolarises but 
is still below firing threshold for approximately  100 ms or more It becomes inactived, 
which leads to tonic firing.  If the cell remains hyperpolarised for 100 ms or more It is once 
again activated and burst firing resumes (Zhan et al., 2000).
The two firing modes mean that relay cells can respond differently to synaptic inputs.  It 
was originally believed that tonic firing occurred only during waking and burst firing only 
during slow-wave sleep or pathological conditions (Steriade et al.,  1993).  It is now 
considered that bursting is part of an attentional mechanism (Crick,  1984) which in the 
LGN may enhance stimulus detection (Guido et al,  1995;Mukherjee & Kaplan,  1995).
The receptive fields of LGN cell are similar to that of retinal ganglion cells (RGCs), ie. on- 
centre, off-surround or vice-versa (Hubei & Wiesel,  1961), although rat LGN cells can 
display an on-off response to visual stimuli (Lennie & Perry,  1981).  Such receptive field 
responses can increase as visual stimulus size increases until the stimulus is large enough to 
stimulate inhibitory circuitry, thereby reducing the excitatory response (Hubei & Wiesel,
1961).  Therefore, LGN output cannot be considered as merely a copy of its input.  In 
addition, centre-surround antagonism is more pronounced in the LGN than in the retina,
64which leads to the conclusion that there is more than one input to a geniculate cell (Hubei 
& Wiesel,  1961).
5.1  Glutamatergic Input
The majority of glutamate present in the LGN is located in the retinal and cortical terminals 
with less seen in GABAergic terminals, glia, dendrites and geniculate cell cytoplasm 
(Montero,  1994).
McCormick and Von Krosigk (1992) reported the presence of a metabotropic glutamate 
receptor on relay cells, the activation of which led to a long lasting EPSP.  This EPSP, 
caused by the reduction of a K+-leak conductance, was able to alter the firing of the relay 
cell from burst to tonic mode.  Furthermore, patch clamp experiments demonstrate the 
presence of functional NMDA and non-NMDA ionotropic glutamate receptors on LGN 
relay neurons (Harata et al.,  1999).
Anatomically mGlu4 and mGlu7 have been located in the LGN by in situ hybridisation 
while mGlu3 can be seen in reticular neurons and possibly also in reticular glial cells (Neto 
et al., 2000).  Functionally, the activation of Group II and III mGluRs leads to a reduction 
in GABAergic inhibition of ventrobasal (VB) relay cells by reticular cells (Salt & Eaton,
1995)  while Group III mGluRs appear to be involved in the modulation of corticothalamic 
transmission (Turner & Salt,  1999).
65Neurons from layer VI of the cortex form a glutamatergic input onto the distal region of the 
dendrites of relay cells mediated by both ionotropic and metabotropic glutamate receptors 
(Sherman & Guillery, 2002).  The existence of a number of different inputs may indicate 
the presence of different ionotropic and metabotropic receptors (Sherman & Guillery,
2001).
5.2  Retinal Input
Retinal Input is topographically mapped onto the LGN (Sanderson,  1971) and is located 
proximally on the relay cell dendritic arbor (Sherman & Guillery, 2002).
Ascending pathways providing input into the LGN include first order input from retinal 
ganglion cells which activate NMDA, non-NMDA receptors (Crunelli et al., 
1987;Scharfman et al.,  1990) and metabotropic glutamate receptors (McCormick & von 
Krosigk,  1992).
The location of mGluRl  has been demonstrated on relay cells, postsynaptic to cortical input 
(Turner & Salt, 2000), but little is found postsynaptically to retinal afferents (Godwin et al., 
1996).  Furthermore, mGluR5 has been localised to F2 terminals associated with retinal 
input to the relay cells.  Thus mGluRl  may be involved in corticogeniculate transmission 
from layer VI while mGluR5 may affect modulation of retinal input via the intemeurons of 
the triadic circuitry (Sherman & Guillery, 2001).
66Furthermore Sillito et al., (1990a and  1990b) have demonstrated that retinogeniculate 
transmission is dependent on NMDA receptors but also involves non-NMDA receptors; the 
blockade of AMPA receptors prevents EPSP generation by optic tract input (Kielland & 
Heggelund, 2001), suggesting their importance in transmission of visual information.
Thus it is possible that retinal synaptic transmission is conveyed by ionotropic receptors 
while it is modulated by both metabotropic and ionotropic receptors (figures 3 and 4) 
(Sherman & Guillery,  1998).
5.3  GABAergic Input
Intemeurons provide two types of inhibitory connection, axonal and dendritic.  Axonal 
connections (FI  terminals) form synapses with dendrites or soma of the relay cells and 
modulate presynaptic activity (Holdefer et al.,  1988).  Dendro-dendritic synapses (F2 
terminals) are also formed between dendrites of the intemeurons and those of the relay cells 
which have both pre- and postsynaptic effects (Montero,  1986).  It is these F2 terminals that 
appear in the triadic synapses found in the glomeruli of the thalamus (Sherman & Guillery,
1996).  The triads consist of a retinal terminal contacting an F2 terminal and a relay cell 
dendrite, and the same F2 terminal contacting the same relay cell dendrite (figure 3).
TRN cell input to relay cells in the cat is GABAergic, and is mostly found on dendrites 
outside glomeruli, but TRN cells do not provide a significant GABAergic input to
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Figure 4.  Synaptic circuitry in the cat LGN.  Reproduced from Guillery and Sherman, 
2002thalamic intemeurons (Wang et al., 2001).  TRN cells can also form F terminals on relay 
cell bodies and dendrites mainly outside thalamic glomeruli (Sherman & Guillery,  1996).
Reticular neurons receive input from collateral branches of thalamocortical and 
corticothalamic afferents (Bourassa & Deschenes,  1995).  The arrangement of projections 
through the reticular cell layer is topographical as is the reticular projection to thalamus 
(Crick,  1984).  While reticular cells activate both GABAa and GABAb receptors on relay 
cells, intemeurons are known only to activate GABAa receptors (Cox et al.,  1998).  It is via 
this GABAergic transmission that the activation of mGluRs on intemeurons inhibits relay 
cell activation via dendrodendritic synapses (Cox et al.,  1998).
Responses mediated by both GABAaRs and GABAbRs have been recorded in rat dLGN 
neurons (Soltesz and Crunelli,  1992).  Three types of GABAR have been identified on local 
intemeurons in the rat dLGN, GABAaRs, GABAbRs, and a class referred to as GABAa- 
bicuculline-insensitive receptors (Zhu and Lo,  1999) which are in all probability 
GABAc Rs.
5.4  Physiological Function
Local intemeurons in the LGN and thalamic reticular cells are involved in feedback 
inhibition (Lo & Sherman,  1994).  It is thought that the temporal summation of GABAa 
receptor activation may be sufficient to de-inactivate It and produce burst firing but this has 
been observed only in slice preparations and anaesthetised animals.  Metabotropic GABAb
70receptor activation would produce a larger, more sustained hyperpolarisation, thereby de­
activating Ij and producing conditions to bring about burst firing.
Attention to a novel stimulus in the environment increases both GABA and glutamate in 
the LGN (Montero et al., 2001).  Visual attention activates the TRN via corticogeniculate 
neurons (Montero, 2000), therefore, the suggestion is that the increase in glutamate is due 
to corticogeniculate activity and the rise in GABA is caused by reticular neuron activation 
by the same corticogeniculate pathway.  The possibility that these changes are caused by an 
increased activity of retinogeniculate afferents, however, is not entirely ruled out.
5.5  Other Input
5.5.1  Nitrergic Input
The release of nitric oxide (NO) from the parabrachial terminals has been suggested to 
cause a change in firing mode as described earlier (Pape & Mager,  1992).  In vivo 
experiments have also demonstrated a nitric oxide mediated enhancement of NMD A 
receptor activation by RGCs (Cudeiro & Sillito,  1996).
5.5.2  Adrenergic Input
Noradrenergic input to relay cells also arises from the parabrachial region (PBR).  The 
activation of metabotropic ai  adrenoreceptors causes inositol trisphosphate (IP3) 
production which leads to the reduction of a K+-leak conductance.  This gives rise to a long, 
slow EPSP, thus promoting tonic firing (McCormick & Pape,  1990a).  The activation of (3
71adrenoreceptors present on relay cells meanwhile alters the voltage-dependence of a 
hyperpolarisation-dependent cation conductance (Ih) (McCormick & Pape,  1990a).  Ih is 
activated during hyperpolarisation to cause a slow depolarising current after the de­
inactivation of It.  In this way the production of a low threshold spike (LTS) and burst 
firing can occur (McCormick & Pape,  1990b).
5.5.3  Cholinergic Input
Cholinergic input from the parabrachial region (PBR) of the brain stem modulates 
geniculo-cortical transmission.  Stimulation of this input causes a fast, ionotropic nicotinic 
receptor activation followed by a slower and more sustained, metabotropic muscarinic 
receptor activation (once again caused by the reduction of a K+-leak conductance)
(Sherman & Guillery, 2001).  As with the EPSP produced by glutamatergic input, 
cholinergic parabrachial input is able to switch the relay cell firing mode from burst to tonic 
firing (McCormick,  1991)
Marks and Roffwarg (1989) state that previous experiments suggested that acetylcholine 
may increase relay cell excitability during waking and rapid eye movement (REM) sleep. 
They demonstrated that acetylcholine (Ach) produced response facilitation during waking 
and REM sleep, but in slow-wave sleep ACh could produce facilitation, inhibition- 
facilitation or no effect on visual response.
725.5.4  Serotonergic Input
The inhibition of relay cells is the result of serotonergic transmission from the dorsal raphe 
nucleus in vivo (Kayama et al.,  1989) probably via the indirect effect on reticular cells 
(Funke & Eysel,  1995).  The effects in vitro are the same as those of (3  adrenoreceptor 
activation (McCormick & Pape,  1990a).
5.5.5  Histaminergic Input
The activation of histamine receptors via hypothalamic input is similar to that of 
noradrenergic receptors; a metabotropic effect possibly via H]  receptors, and an alteration 
of Ih voltage-dependency mediated by H2  receptors (McCormick & Williamson,  1991).
5.6  Modulation of Input
Modulation and transmission are via both metabotropic and ionotropic receptors.  The 
slower (>10 ms) response of metabotropic (mGluR, GABAb) receptors is more appropriate 
for modulation of synaptic transmission as their slower and more prolonged depolarisations 
may be involved in switching thalamic relay cells between burst and firing modes 
(Sherman, 2001).  The faster activation of ionotropic (NMDA, AMPA, KA, GABAa) 
receptors means they are more suited to synaptic transmission (Sherman, 2001).
Most synapses located in the thalamus modulate the relay functions of the LGN (Sherman,
2001).  One role of this modulation is to alter information transfer depending on current 
attentional demands. Therefore one can expect the modulation that occurs to affect 
ascending and corticocortical pathways (Sherman & Guillery, 2001).
73Modulatory afferents arise from the cortex and brain stem to have direct actions on the 
relay cells of the LGN or to act indirectly via local inhibitory intemeurons or cells of the 
thalamic reticular nucleus (Guillery & Sherman, 2002).
It is seen that retinal (‘driving’) synaptic transmission is conveyed by ionotropic receptors 
while modulatory input is mediated via metabotropic and ionotropic receptors (see Fig 4 for 
a summary of receptors, efferents and afferents) (Sherman & Guillery,  1998).
It is possible that GABAergic input from intemeurons and reticular cells could alleveate Ij 
inactivation via hyperpolarising IPSPs to produce burst firing (Kim et al.,  1997).  It is also 
possible that the GABAergic modulatory effects can be mediated by retinal afferents, by 
feedback from relay cells themselves, and by layer 6 and brainstem afferents (Blasdel & 
Lund,  1983;Humphrey etal.,  1985).
746  The Superior Colliculus
6.1  Organisation of the SC
The superior colliculus forms the rostral part of the tectum in the midbrain.  It is thought to 
play a role in integrating sensory information (visual, auditory, somatosensory, 
nociception) and converting the integrated signal into motor signals that help orient the 
head toward various stimuli (Stein & Meredith,  1993).  Stimulation  of  SC neurons also 
initiates non-visual responses to novel stimuli such as changes in heart rate, blood pressure 
and respiration (Keay et al.,  1988).  Thus the SC is also involved in producing appropriate 
defensive behaviour.
The superior colliculus is a laminar structure comprising seven alternating cell and fibre 
layers (Kanaseki & Sprague,  1974), functionally organised into two regions.  The three 
dorsal layers are known as the superficial subdivisions (stratum zonale, stratum griseum 
superficiale and the stratum opticum), and the four deeper layers (stratum griseum 
intermediale, stratum album intermediale, stratum griseum profundum, and stratum album 
profundum) known as the deep subdivisions.  This organisation is based on projections to 
and from the layers, physiological properties and behavioural response (Harting et at., 
1973; Edwards,  1986; Binns,  1999).
Both superficial and deep subdivisions contain topographically arranged, visually 
responsive neurons which together form a retino-topic representation of contralateral visual 
space (Chalupa & Rhoades,  1977;Drager & Hubei,  1976).
756.2  Superficial Layer Input
The superficial layers of the SC are exclusively involved in processing visual information 
(Casagrande et al.,  1972).  Each colliculus receives contralateral retinal afferents, and also 
cortical afferents from layer V of the visual cortex which can form synapses on the same 
neuron in the SGS (Binns,  1999).
Dendrites can extend up to  1.2-1.4 mm (Moschovakis & Karabelas,  1985) and, therefore, 
are able to cross between the upper layers and even between deep and superficial 
subdivisions of the SC (Behan & Appell,  1992;Moschovakis et al.,  1988;Moschovakis & 
Karabelas,  1985).
6.3  Deeper Layer Input
The SC receives input from ascending and descending sensory pathways.  Both pathways 
interact to integrate experience with attention and response (Binns,  1999).
Deeper layers receive auditory, somatosensory and nociceptive inputs and inputs from 
motor-related structures and multi-modal input from the anterior ectosylvian (AES) sulcus 
(Clemo & Stein,  1982).  A large ascending somatosensory input comes from the trigeminal 
complex, dorsal column nuclei, lateral cervical nucleus and spinal cord (Blomqvist et al., 
1978;Edwards et al.,  1979;Huerta & Harting,  1984).  Other ascending inputs include 
mainly contralateral auditory projections from the brachium of the inferior colliculus, 
external nucleus of the inferior colliculus and an area medial to the trapezoid body
76(Edwards et al.,  1979).  Descending input arises from the auditory field of the AES sulcus 
(Meredith & Clemo,  1989).
Somatosensory cortical afferents are arranged topographically (Clemo & Stein,  1982) from 
the anterior ectosylvian sulcus (SIV) (McHaffie et al.,  1988) and rostral lateral suprasylvian 
sulcus (Stein et al.,  1983).
Visual input to deeper layers includes that from extrastriate regions eg, lateral suprasylvian 
visual area (Berson,  1985), anterior ectosylvian visual area (Wallace et al.,  1991).  There is 
little retinal input to the deep layers (Berson & Mcllwain,  1982;Mize,  1983a;Mize,  1983b), 
but the little there is mainly connects with the contralateral rostral SC (Beckstead & 
Frankfurter,  1983).
6.4  Superficial Layer Output
Neurons of the upper superficial grey layer SGS of the SSC project to the dorsal and lateral 
geniculate nuclei (upper SGS), while neurons of the lower SGS project to the lateral 
posterior nucleus (lower SGS) and the pretectum (Huerta and Harting,  1984 for review). 
Neurons of the optic layer also provide both excitatory and inhibitory input to the 
contralateral superior colliculus (Olivier et al,. 2000).  This commissural 
glutamatergic/GABAergic input may provide a balance of control for the production of 
orientation and avoidance behaviour (Olivier et al.,  1998, 2000).
77The superficial SC also sends topographically mapped excitatory efferents (Wang et al., 
1988; Bennett-Clark et al.,  1989) to the ipsilateral parabigeminal nucleus (Sherk,  1979; 
Harting et al.,  1980; Taylor et al.,  1986).  This connection in turn forms an inhibitory 
feedback mechanism which modulates retinal input onto collicular neurons via its 
cholinergic transmission onto intemeurons (Binns & Salt, 2000).  Neurons from the SGS 
project to the pretectal complex (Kubota et al.,  1989), which also provides ipsilateral 
feedback to the SC (Edwards et al.,  1979; Weber & Harting,  1980).
Projection neurons of the SGS also make connections with cells of the dLGN (Kawamura 
et al.,  1980; Harrell et al.,  1982; Sugita et al., 1983; Harting et al.,  1991).  These respond to 
static or slow-moving stimuli and have small receptive fields which show central 
summation and centre-surround suppression (Albano et al.,  1978).  Once again these 
projections are topographically arranged in all species but targets are species specific due to 
variation in dLGN organisation (Harting et a!.,  1991).
6.5  Input to Both Layers
Motor afferents include mainly ipsilateral input from the frontal eye fields (Kawamura & 
Konno,  1979;Leichnetz,  1981) and the motor cortices (Leichnetz et al.,  1987) involved in 
oculomotor behaviour.  More motor input comes from the basal ganglia (Westby et al.,
1994)  and substantia nigra pars reticulata which synapse with SC efferents.  There are also 
oculomotor inputs from the zona incerta, thalamic reticular nucleus and posterior 
commissure nucleus.
78Other afferents arise from the deep nuclei of the cerebellum and the perihypoglossal 
nucleus (May et al.,  1990), and the contralateral SC, locus coeruleus, raphe dorsalis, 
parabrachial nuclei, reticular formation and hypothalamus (Edwards et al.,  1979).  There 
are additional inhibitory inputs from the substantia nigra and the zona incerta (Appell & 
Behan,  1990;Araki etal.,  1984;Ficalora & Mize,  1989).
It is this variety of inputs which allows the integration of sensory input to produce an 
appropriate motor response.
6.6  Deeper Layers Output
Deep layer efferent projections can ascend to the thalamus, connect with the contralateral 
SC, or descend to the brainstem and spinal cord, in a crossed or uncrossed arrangement 
(Huerta & Harting,  1984).  The possible functions of these connections would be for 
alerting higher centres to activity in the deep layers, coordinating activity in the two 
colliculi (Edwards,  1977;Edwards & Henkel,  1978), and the production of behavioural 
responses to stimuli (ie moving eyes, head, limbs, pinnae, whiskers) (Dean et al., 
1986;Huerta& Harting,  1984).
6.7  Interlaminar Connection
There is little interconnection between the superficial and deep layers, however, some have 
found superficial layer projections to the deeper layers in hamster (Rhoades et al.,  1989) cat 
(Behan & Appell,  1992) and monkey (Moschovakis et al,  1988).  Also seen are deep layer
79dendrites extending into superficial layers in cat (Moschovakis & Karabelas,  1985), 
suggesting inter-laminar interaction does occur (Mooney et al.,  1988).
6.8  Glutamate Receptors
Deafferentation of retinal and cortical input reduces the concentration of glutamate in the 
SC (Fosse et al.,  1984;Sakurai et al.,  1990;Sakurai & Okada,  1992).  Supporting this 
evidence of glutamatergic synaptic transmission, the use of immunohistochemistry has 
localised glutamate in both retinal and cortical synapses in the SC (Mize & Butler,  1996; 
Jeon et al.,  1997).
6.9  Ionotropic Glutamate Receptors
The iontophoretic ejection of NMDA antagonists, AP5 or CPP, affects most neurons in the 
SGS, however, there appear to be two different populations of neuron present; an AP5- 
sensitive and an AP5-resistant population (Binns and Salt,  1994 ).  These appear to be 
located in three sub-layers of the SGS in the cat SSC.  In the cat, the inhibition of cortical 
input into the SGS confers an AP5-resistant state on previously AP5-sensitive neurons of 
the SGS (Binns & Salt,  1996b).  This information along with the localisation of NMDA 
receptors at both cortico-collicular and retino-collicular synapses may suggest a co­
activation of retinal and cortical afferents, possibly for the enhancement of attention to 
environmental stimuli (Binns,  1996b).
80The selective block of cortico-collicular NMDA receptors and lesioning of discrete areas of 
the visual cortex demonstrates that tuning properties of SGS neurons are due to sub-cortical 
and not cortical influence (Binns & Salt,  1996a;Mendola & Payne,  1993).
Response habituation to visual stimuli in the SSC is seen if stimuli are presented with a 
small inter-stimulus interval (Oyster & Takahashi,  1975;Binns & Salt,  1995;Binns & Salt,
1997).  The use of locally applied NMDA or non-NMDA antagonists reduces this 
phenomenon and supports the suggestion that visual stimuli activate both excitatory retino- 
collicular pathways and intrinsic inhibitory circuits (Oyster & Takahashi,  1975).  Both 
NMDA and non-NMDA receptors may be involved in the inhibitory mechanisms which 
lead to response habituation in the SSC (Binns & Salt,  1995).
Both NMDA and non-NMDA receptors have been located in the SC (Chalmers & 
McCulloch,  1991 ;Kiyosawa et al.,  1996).  NMDAR1  subunits have been localised by 
electronmicroscopy postsynaptically on cell bodies and dendrites apposed to retinal and 
cortical terminals in the SGS and upper optic layers.  These subunits are also found in 
postsynaptic locations of presynaptic dendrites of GABAergic neurons (Mize & Butler, 
2000).
Both functional GluR2-containing AMPA receptors and those lacking GluR2 subunits have 
been located in the SSC (Endo & Isa, 2001).
81Previous slice experiments have shown an interlaminar connection between the superficial 
and deeper layers of the SC, superficial layer (SGS) stimulation produced a non-linear, 
NMDA-dependent, burst response in deeper layer (SGI) neurons (Isa & Saito, 2001).  The 
response threshold of this connection can be modulated by the activation of cholinergic 
nicotinic receptors via input to the SGI layer.  It is considered important in the initiation of 
saccadic eye movements (Aizawa et al.,  1999).
Although immunohistochemistry and functional investigation of KARs has yet to be 
performed, there is a significant expression of GluR5 mRNA in the SGI (Wisden & 
Seeburg,  1993).  In addition all subunits are diffusely but moderately expressed  throughout 
the SC (Wisden & Seeburg,  1993) and autoradiography shows low, uniform KA binding in 
the midbrain (Monaghan & Cotman,  1982).  Enucleation experiments have also suggested 
that KARs may influence the development of the visual system in the superficial superior 
colliculus (Kiyosawa et al.,  1996; Chalmers an McCulloch,  1991)
6.10  Metabotropic Glutamate Receptors
Both mGluRl  and mGluR5 have been localised in the SC (Cirone et al., 2002b;Shigemoto 
et al.,  1992).  A greater amount of mGluR5 reactivity was observed with the possibility of 
some localisation to retinal afferents in the SSC (Cirone et al., 2002b).  Both in vivo and in 
vitro activation of mGluRl  in the SSC inhibits visual responses, possibly by inhibiting 
presynaptic glutamate release from retinal or cortical input (Cirone et al., 2002a).
82The Group II receptors, mGluR2 and mGluR3, are both located in the optic tract and SSC 
(Cirone et al, 2002b).  The activation of Group II receptors may be involved in contrast 
adaptation in the SSC (Cirone & Salt, 2001).  It has been suggested that Group II mGluRs 
mediate presynaptic inhibition in retinotectal synapses by the inhibition of N-type calcium 
channels in retinal ganglion cells (Zhang & Schmidt,  1999).
A high concentration of the Group III receptor, mGluR4, is found in the SSC, possibly in 
retinal terminals (Cirone et al., 2002b).  Immunohistochemistry has also localised 
mGluR7a in SSC (Kinoshita et al.,  1998), possibly in fibre tracts (Bradley et al,  1998). 
Activation of Group III receptors increases response habituation to visual stimuli, again 
probably by presynaptic inhibition of glutamate release (Cirone & Salt, 2001).  Functional 
mGlu8 demonstrated in the SGS shown to reduce synaptic transmission on stimulation of 
the retinal and possibly cortical afferents (Pothecary et al., 2002).
6.11  GABA Receptors
6.11.1  Distribution of GABAergic neurons in the SC
Approximately 50% of SC neurons appear to be GABAergic (Okada,  1992). 
Immunohistochemistry for GABA and glutamic acid decarboxylase (GAD) indicate a high 
level of GABA in the SC, especially in the SGS.  GABAergic neurons are found 
throughtout the SC but do not appear to follow the laminar structure of the projection 
neurons (Mize et al.,  1991).  However, concentration of GABAergic neurons present 
appears to be linked to total neuronal density in each layer, therefore, highest distribution is
83found in the zonal layer and upper SGS, but they are also located throughout the SC (Mize 
et al.,  1991).
GABA has been localised to the dendrodendritic processes of horizontal cells, which 
receive around half of their input from the visual cortex, pyriform and stellate cells (Mize,
1992).  Autoradiography also shows that GABAa and GABAb receptors are present 
throughout the SC (Bowery et a/.,  1987) while GABAc mRNA has been localised in the 
SGS (Boue-Grabot et al.,  1998;Wegelius et al.,  1998).
6.11.2  GABAergic projections to the SC
There are at least three extrinsic GABAergic inputs onto neurons of the SC, from the 
substantia nigra (Araki et al.,  1994; Ficalora and Mize,  1989), zona incerta (Araki et al., 
1994; Ficalora and Mize,  1989) and contralateral colliculus (Appell and Behan,  1990).  In 
the cat, other GABAergic projections have also been studied, including the cuneiform 
nucleus, the subcuneiform area, the peri-parabigeminal area, the inferior colliculus, lateral 
lemniscus nuclei, perihypoglossal nucleus and several pretectal nuclei (Appell and Behan, 
1990).
The pathway from the substantia nigra (SN) inhibits neurons of the intermediate and deep 
grey layers of the SC (Deniau et al.,  1978;Chevalier et al.,  1981). This pathway is involved 
in the release of SC neuron inhibition prior to saccadic eye movements (Hikosaka and 
Wurtz,  1985a;  1985b).  Lesioning studies in the SN further support the observation that the
84inhibitory input from this nucleus is via GABA transmission; GAD is reduced in the deeper 
layers of the SC after lesions of the SN (Vincent et al.,  1978).
The zona incerta (ZI) similarly provides a GABAergic input to the intermediate and deep 
grey layers (Ricardo,  1981; Rieck et al.,  1986), connections which may play a part in the 
production of orienting behaviour (Kim et al.,  1992).  There is also GABAergic 
commissural input to the intermediate grey layer from the contralateral intermediate grey 
layer (Edwards,  1977; Edwards et al.,  1979) which is thought to provide contralateral 
suppression of excitation during stimulus presentation (Munoz & Istvan,  1998).
6.11.3  Distribution
GABAaRs appear to be highly expressed in superficial layers, but are also present in the 
deep layers of the SC (Bowery et al.,  1987).
GABAbR localisation also appears to be denser and more specific to the superficial layers 
of the SC (Bowery et al.,  1987; Gehlert et al.,  1985).  Baclofen sensitive GABAbRs do not 
respond to bicuculline application (Hill and Bowery,  1981).  Binding studies for GABAbRs 
using tritiated muscimol demonstrate intermediate binding in the superficial grey layer but 
lower affinity binding in the deep layers of the rat SC (Palacios et al.,  1981).
The GABAcR subunits, pi and p2, have been shown by in situ hybridisation and reverse 
transcription-PCR (RT-PCR) to be present in the rat SC (Albrecht et al.,  1997; Wegelius et 
at.,  1998).  These inhibitory receptors appear to be selectively expressed by intrinsic SGS 
interneurons (Schmidt et al., 2001; Boiler and Schmidt, 2003).
85Thus all three types of GABAR are found in the SC and furthermore, appear to undergo 
alteration in postnatal distribution indicating a role in SC development (Clark et al., 2001).
6.11.4  Physiology
It has been demonstrated that the SSC contains a high concentration of inhibitory 
GABAergic intemeurons (Mize,  1992), which may be important in centre-surround 
inhibition and habituation responses of the SC (Binns & Salt,  1997a; Binns & Salt,  1997b).
GABAa and GABAb receptors have been shown to have different roles in the modulation 
of responses in SGS neurons.  GABAa receptors modulate centre-surround responses, 
while GABAb receptors are involved in response habituation (Binns & Salt,  1997a). 
Furthermore, GABAb receptors may be located pre- or postsynaptically on either inhibitory 
or excitatory projections in the SSC (Endo & Isa, 2002).
GABAcRs subunits are activated by concentrations of GABA and muscimol that do not 
activate GABAaRs to increase excitatory transmission in cells of the SC thought to be 
projection neurons (Pasternack et al.,  1999; Schmidt et al., 2001).
In the SGS of the SC, GABAC  R activation is suggested to exert a disinhibitory effect on 
projection neurons by reducing GABAergic transmission from intemeurons (Boiler and 
Schmidt, 2001; Schmidt et a!., 2001).
86GABAcRs appear to be selectively expressed by intrinsic SGS intemeurons (Schmidt et al., 
2001; Boiler and Schmidt, 2003), but they are not activated by optic layer stimulation 
(Boiler and Schmidt, 2003).  This suggests, therefore, that input other than that from the 
retina and visual cortex is able to activate GABAcRs on GABAergic intemeurons located 
postsynaptically to retinal and visual cortex input in order to disinhibit projection neurons 
(Boiler and Schmidt, 2003; Pasternack et al.,  1999; Schmidt et al., 2001).
In addition to postsynaptic GABAcR activity, a presynaptic location is also suggested by 
cell culture studies (Kirischuk et al., 2003).  Although GABAcRs do not appear to mediate 
evoked IPSCs in culture, they do contribute to paired-pulse depression.  Therefore, these 
presynaptic receptors are able to modulate synaptic transmitter release in a frequency- 
dependent manner (Kirischuk et al., 2003).
877  Aims Of The Investigation
Until relatively recently, pharmaclological tools have not been selective enough to 
distinguish between AMPARs and KARs.  Due to the emergence of new, more selective 
agents, establishing roles for KARs in synaptic function has now become possible and 
attracted more interest.  In the current study, GluR5 subunits in particular have been studied 
using pharmacological agents that are specific for these subunits.  These compounds 
include the agonist ATP A (Clarke et al.,  1997) and the antagonists LY3 82884 (Bleakman 
et al,  1999) and UBP296 (More et al., 2004).
KARs have been located both pre-and postsynaptically and implicated in both the increase 
and reduction of GABAergic and glutamatergic transmission.  Studies have also shown that 
this receptor group has a possible postynaptic involvement in neurotransmission.  In 
addition there is evidence from both autoradiography (Monaghan & Cotman,  1982) and in 
situ hybridisation (Wisden & Seeburg,  1993) demonstrating that all KAR subunits 
including GluR5 are found in the SC.  With the possibility of diverse roles in synaptic 
transmission and modulation, KARs may well play an important part in the processing of 
visual information in the SC and LGN.
To investigate whether GluR5 KARs are directly involved in synaptic transmission from 
RGCs to relay cells of the LGN and neurons of the SSC.
To elucidate the involvement of GluR5 KARs in visual processing both in vivo and in vitro 
methods will be used.  In vivo electrophysiology will be used for extracellular recording of 
evoked neuronal activity.Tungsten electrode recording and i.v. injection of GluR5 antagonist will be used to provide 
an indication of GluR5 actvity in the LGN and SSC.  In vivo recording along with 
iontophoretic administration of GluR5-specific pharmacological compounds will also be 
employed to investigate the participation of KARs in direct synaptic transmission between 
RGCs and the LGN and SSC.
To parallel in vivo protocols, in vitro LGN and SC slice experiments will be undertaken. 
These will include studying the effect of GluR5 agonists and antagonists on single and 
paired evoked postsynaptic potentials.  This will enable the application of drugs at 
concentrations specific for GluR5 subunits whilst investigating GluR5 involvement in 
direct synaptic transmission between RGCs and SSC neurons.
To investigate whether GluR5 KARs are involved in synaptic transmission or modulation in 
response to different types of visual stimuli in vivo.
A variety of visual stimuli can be used to observe phenomena such as response habituation 
and centre-surround inhibition which occur in both the SSC and LGN.  Response 
habituation can be produced successfully with relatively high stimulus frequency, while 
increasing the size of visual stimuli can produce centre-surround inhibition.  The use of 
specific compounds may reveal a modulatory role for GluR5-containing receptors in the 
glutamatergic or GABAergic transmission involved in these responses.
89In addition, the evidence for GluR5 involvement in high frequency synaptic activity may be 
investigated using a contrast sensitivity protocol.  As the strength of the stimulus increases, 
the frequency of RGC-SSC and RGC-LGN transmission will increase.  The iontophoresis 
of GluR5-specific drugs during these stimuli may demonstrate an involvement of these 
receptors in high frequency synaptic transmission.
To investigate whether GluR5 KARs are involved in (a) postsynaptic visual transmission or 
(b) presynaptic modulation of visual transmission via an excitatory or inhibitory pathway
Using a paired pulse protocol during the application of GluR5-specific pharmacological 
agents will give an indication as to the pre- or postsynaptic location of these receptors. 
Additionally, the use of GluR5-specific compounds during perfusion of glutamate receptor 
or GABAR-specific antagonists will reveal the involvement of GluR5-containing receptors 
in either excitatory or inhibitory pathways in the SSC and LGN.  Furthermore it may be 
possible to correlate any KAR activity with either RGC or cortical input into the LGN.
This can be done by separately stimulating the retinal or cortical pathways into the LGN in 
slice preparations.
908  Methods
Pharmacological compounds used in this research are summarised in the appendix.
8.1  in vivo investigation
8.1.1  Experimental Preparation
Hooded Lister rats of either sex, weighing 250g - 375g were used for all experiments.
The animal was lightly anaesthetised using halothane until the righting reflex was lost. 
Longer term anaesthetic was induced using  1   g/kg urethane which was topped up if 
necessary until the pedal withdrawal reflex disappeared.  Subcutaneous injection of 
lignocaine (2% w/v) with adrenaline (0.011  mg/ml) was used at all wound margins.
To maintain the airway throughout the experiment a tracheostomy tube was inserted.  This 
was achieved by cutting the skin to access muscle around the trachea.  The trachea was 
freed from the surrounding muscle and connective tissue by blunt dissection.  Using a 
scalpel an incision was then made in the trachea between two rings of cartilage through 
which a glass cannula was inserted.  The cannula was secured and the trachea tied off with 
nylon sutures.  The skin was closed over the tracheostomy with three or four sutures, 
leaving the end of the cannula exposed.
The animal was then transferred to a stereotaxic frame and secured in place with a nose bar 
and blunt ear bars the tips of which were coated with lignocaine gel.
91Throughout the experiment the animal’s temperature was maintained at 37°C by means of a 
temperature probe placed next to the abdomen linked to a heating pad below the animal.  In 
addition the heart rate was recorded throughout via gold electrodes attached to the hind paw 
and front paw with adhesive tape.  A small amount of electrocardiogram (ECG) gel was 
applied between the electrodes and the skin to aid recording.  At this point sterile eye drops 
were applied to prevent corneal drying.
To prepare for a craniotomy, an incision was made in the skin on the dorsal surface of the 
skull and held apart with clamps while muscle and connective tissue was gently scraped 
from the bone.  Using stereotaxic coordinates (Paxinos & Watson,  1998) the skull was 
marked and the bone carefully drilled out to expose the brain.  In addition holes were 
drilled in the bone to which a head holder and electroencephalogram (EEG) leads were 
attached with screws.  The head holder and EEG leads were further secured to the bone 
using dental cement which also acted as an insulator for the EEG leads.
The dura mater was removed from the surface of the brain using a new small gauge syringe 
needle.  Following this the nose bar and one side of the stereotaxic frame and ear bar were 
also removed and the animal was electrically grounded via a silver wire secured through the 
skin in the back of the neck.
Warm agar was applied to the surface of the brain once the electrode had been lowered in 
order to minimise dehydration and recording instability due to brain movement.
92Once neurons were located, single unit extracellular recordings were made in response to 
visual stimuli produced by a Picasso visual stimulus generator controlled by VS software 
placed in the centre of the cell’s receptive field.  Stimuli were displayed on a CRT (cathode 
ray tube; Tektronix) display positioned 10 cm from the contralateral eye.
Additional 0.1  ml injections of urethane were administered when necessary (i.e. when the 
pedal withdrawal reflex returned or when an increase in heart rate was observed.  Animals 
were sacrificed at the end of the experiment with an overdose of urethane.
8.1.2  Systemic Injection
In order to administer drugs systemically a second incision was made in the skin overlying 
the femoral vein.  Surrounding muscle and connective tissue were removed by blunt 
dissection and the vein tied off and held taught with a clamp attached to the suture.  The 
outer edge of the vein was held with fine forceps while an incision was made using scissors 
through which a Krebs-filled cannula was then inserted and tied in place with a suture.  The 
skin was closed with three or four sutures.  To investigate the effect of GluR5 antagonist on 
LGN neurons, 50mg/kg LY382884 was injected via the cannula after control values were 
recorded.  Identical volumes of the vehicle were also injected either before or after drug 
injections to test for non-specific effects on visual response.  The protocol was repeated 
whilst recording visual responses from RGC axons in the optic chiasm.
Optic chiasm recordings were made in addition to those in the LGN to explore the 
possibility that the systemically injected GluR5 antagonist could be exerting an effect at
93KARs in the retina itself.  GluR5 receptors have previously been found postsynaptically on 
bipolar cells in the retina of the ground squirrel (DeVries and Schwartz,  1999), therefore it 
seemed logical to examine the possibility of GluR5 involvement in retinal processing in the 
rat retina using this technique.
8.1.3  LGN and Optic Chiasm Recording
Stereotaxic coordinates were used to position a tungsten electrode over the location of 
either the LGN or the optic chiasm and lowered using a microstepper control until visually 
responsive neurons were located.
8.1.4  Iontophoresis
To record from SC neurons a craniotomy made slightly rostral to the position of the SC. 
This was to ensure the SC was located successfully using an angled penetration which 
would avoid the overlying visual cortex.  To position the tungsten electrode correctly it was 
lined up at the level of the SC on a spare frame before transferral to the stereotaxic frame 
and placed according to previously calculated coordinates ready for penetration into the 
brain.
Silver wire was inserted into the solutions in each barrel and the ends of the barrels were 
sealed with a small amount of petroleum jelly.  The electrode was then slowly advanced 
through the brain to the SC using a microdrive stepper, at an angle -15° to the vertical in 
order to avoid the overlying visual cortex (figure 5).
94Electrode resistance was measured by passing a 50nA current through the each of the 
barrels.  Low resistances indicated that there is the possibility of drug leakage from the 
barrels.  High barrel resistance would be detrimental to the ejection of drug solutions.
Neuronal responses were recorded via a central barrel containing 4M NaCl, while current 
balancing was achieved via one of the outer barrels containing 1M NaCl (see figure 6 for 
experimental setup).  Drug solutions were ejected by passing current through the silver wire 
inserted into the barrels.  Drug ejection and current balancing was controlled by a 
Neurophore iontophoretic pump unit.
8.1.5  Response Detection and Recording
Evoked action potentials were viewed on an oscilloscope with individual cell responses 
isolated using a waveform discriminator.  These gated neuronal responses were amplified 
xlOOO using an Axoprobe amplifier (Axoprobe  1  A, Axon Instruments) and connected to a 
computer via a CEDI401  interface to be recorded by VS software (Cambridge Electronic 
Design, Cambridge, UK).  The data were collected as peri-stimulus time histograms 
(PSTHs) and analysed using Spike 2 software (Cambridge Electronic Design Limited).
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Figure 6. Experimental arrangement for recording from visually stimulated SC neurons8.2  In vitro slice recording
Adult Hooded Lister rats were anaesthetised with halothane and decapitated in accordance 
with the UK Animals (Scientific Procedures) Act 1986.  The brains were rapidly removed 
and placed in oxygenated (95% 02/5% CO2) ice-cold Krebs containing (mM): sucrose 202, 
KC1 2, KH2PO4  1.25, MgS04 10, CaCh 0.5, NaHC03 26, glucose  10.  The cerebellum was 
removed and an angled cut of approximately 45° to the midline was made
The cerebellum was removed and an angled (approximately 45 deg to the midline) cut 
made across the frontal cortex. The block of brain was glued to the cutting stage of a 
vibratome (Campden Instruments) from which 300 pm slices of the SC were prepared. In 
this way the integrity of retinal input to the superficial layers of the SC is maintained as it 
enters the SC. The slices were transferred to oxygenated Krebs medium containing (mM): 
NaCl  124, KC1 2, KH2P 04  1.25, M gS04 5, CaCl2  1, NaHC03  26, glucose  10.
After one hour, slices were transferred to a submerged recording chamber and held in place 
using a steel washer from which a quarter had been removed and replaced with a strip of 
nappy liner which had been glued into place using cyanoacrylate adhesive.  The liner was 
used to stabilize the medial part of the SSC during continuous perfusion with oxygenated 
(95% 02/5% CO2) Krebs solution containing (mM): NaCl  124, KC1 2, KH2PO4   1.25, 
MgSCL  1, CaCh 2, NaHC03 26, glucose  10.  Drugs were applied to the bath in the Krebs 
perfusate.
98For recording IPSCs a monopolar or bipolar tungsten-in-glass stimulating electrode was 
positioned in the upper half of the SGS.  To record EPSCs the stimulating electrode was 
placed in the optic tract.
Patch recording electrodes were pulled on a Sutter microelectrode puller (Sutter Instrument 
Co., USA) using filamented capillary tubes (Harvard Apparatus, UK) and filled with an 
internal solution of (in mM): Potassium gluconate  130mM, NaCl 5mM, EGTA 0.5mM, 
HEPES  lOmM, GTP 0.4mM, ATP 4mM, QX314  lOmM, biocytin 0.1%.  Electrode 
resistances varied between 6.5 and  17.5 MQ.
Responses were recorded with an Axoclamp-2B amplifier (Axon Instruments), digitised 
(10 kHz) via a CEDI401  interface and stored on a computer with Spike2 software 
(Cambridge Electronic Design).  Recordings were filtered at 3 kHz during acquisition.
To investigate GluR5 involvement in the modulation of inhibitory input into SGS neurons, 
the effect of the GluR5 agonist, ATPA, was observed on IPSCs.  In order to isolate KAR 
affects, all other glutamate receptors were blocked using a cocktail of D-AP5, GYKI52466, 
CPPG and LY393053, which antagonize NMDA, AMPA, mGlu4, 6, 7 and 8 (Group III), 
and mGlul, 2, 3 and 5 (Group I and II) respectively.
An enhancement of the IPSC was achieved by voltage-clamping the membrane potential at 
-50m V in order to study GluR5 involvement more clearly.
99Glutamate antagonists were applied for 20-30 minutes prior to a  10 minute perfusion of 
ATPA.  ATPA was then washed off for a period of 25-30 minutes.  During this time, paired 
IPSCs were evoked with stimulation of between 40-100 volts of duration 0.04ms at  10 
second intervals.
To study GluR5-mediated effects on EPSCs, retinal input into the SSC was stimulated with 
a tungsten-in-glass electrode placed in the optic tract outside the SC.  To investigate the 
affect of GluR5 activation and block on the excitatory transmission alone, GABAergic 
transmission was blocked with  10 pM bicuculline and 3pM CGP55845A (GABAa and 
GABAb antagonists respectively) before applying ATPA at varying concentrations.  The 
GluR5 antagonist, UBP296 was applied in some experiments.  To clearly isolate GluR5- 
mediated actions some experiments were also carried out in the presence of the AMPAR 
antagonist GYKI52466.
Although GABAcR subunit expression has been demonstrated in the superior colliculus, 
they do not appear to be activated by intrinsic GABAergic intemeurons (Boiler & Schmidt, 
2003); evoked IPSCs from optic layer stimulation can be blocked completely by the 
GABAaR antagonist bicuculline, indicating that the intrinsic inhibitory input to SGS 
projection neurons is via GABAaRs alone.  Moreover, afferents activating GABAcRs in 
the SC do not appear to be located with the retinal input into the SC and it is not possible to 
activate them by electrical stimulation of the optic layer (Boiler & Schmidt, 2003).
100For these reasons it was considered unnecessary to block GABAcRs as these receptors 
were unlikely to be activated during the stimulus used in the study of possible GluR5 
effects on excitatory transmission in the SGS.
Analysis was carried out using Spike 2 software to produce waveform averages of 6 
responses from which EPSC/IPSC amplitude and changes in holding current were 
measured.
8.3  Histology and Confocal Microscopy
Following whole-cell recording the slices were placed in phostphate buffered saline (PBS) 
containing 4% paraformaldehyde and stored at 4°C for 24 hours.  Slices were then 
transferred to a solution of 30% sucrose in PBS for 24-48 hours for cryoprotection.  Prior to 
visualisation slices were washed in 30% sucrose +  12% glycerol, twice for 30 minutes, for 
further cryopreservation.
In order to permeabilise the slices to allow the fluorophore access to the biocytin within the 
cells, they were subjected to a freeze-thaw protocol. Each slice was placed individually in a 
foil package and held just above the surface of liquid nitrogen for 30 seconds.  They were 
then brought back to room temperature until the resulting condensation evaporated.  This 
procedure was repeated three times.
101The cryoprotectant was removed by washing slices three times for ten minutes with PBS 
before incubating with a streptavidin, rhodamine red- X conjugated complex (1:200) 
(Invitrogen, Paisley, UK) for two hours at room temperature.
Finally the slices were washed three times for ten minutes in PBS before transfer to a 
gelatin-coated microscope slide, and coverslipping with Vectorshield fluorescent mounting 
medium (Vector Laboratories, Peterborough, UK).
Cells were imaged with a Zeiss laser scanning confocal microscope (LSM510; Carl Zeiss 
Meditec, Oberkochen, Germany) using a  16x or 40x oil immersion objective at 543nm. 
Images were analysed using the LSM 5 image browser.
8.4  Electrode Manufacture
8.4.1  Tungsten Electrodes
Tungsten-in-glass electrodes were made by etching pre-straightened tungsten wire in 
Levick’s solution (Levick,  1972), a NaNo2/KOH solution.  The wire was then insulated in 
glass.  Excess glass was removed from the tip to expose a small amount of tungsten wire, 
which was re-etched to create a tip of 20-30 pm.
8.4.2  Multi-Barrel Iontophoresis Electrodes
To create the electrodes for iontophoresis, four thin-walled, filamented, borosilicate glass 
capillary tubes were taken, three of which were cut in half using a diamond cutter.  The six
102shorter lengths were then arranged around the longer central tube and the assembly was 
held together at either end using two pin vices.  The central area between the vices was held 
in a Bunsen burner flame while the tubes were fused together by gently twisting.  Once 
fused, the vices were pulled apart and the resulting blanks were completed by heating the 
unfused ends and angling them away from the central barrel.  This procedure was 
performed to facilitate barrel filling without drug cross-contamination.
Electrode tips were then pulled to the desired shape and width.  This was achieved by 
fusing a weighted glass tube to the tip.  The tip was then elongated and refined by rapidly 
heating and dropping the unwanted glass from the tip.
Prior to use, the electrode tip was broken back to 8-9 pm under the microscope and filled 
with recording, current balancing and drug solutions.  The electrode was filled before the 
experiment preparation to ensure the absence of air bubbles and that the tips of the barrels 
were filled.  The solutions used were 4 M NaCl for recording,  1   M NaCl for current 
balancing,  10 or 50 mM AMPA, 40 mM ATPA and 50 or  100 mM NMDA.  In some 
experiments 40mM D-AP5 was used to validate the technique of iontophoresis.  All drug 
solutions were retained with small positive currents and ejected as anions.
8.5  LGN Stimulus Protocols
8.5.1  Centre-surround
Spot sizes of 5°,  10° and 20° of visual space and luminance of 35 cd m'2 were used along 
with a blank stimulus.  Four presentations of each stimulus were presented for a two second
103duration in a randomised sequence.  These trials were repeated three times in a cycle and 
the cycle was repeated at  10 minute intervals.
8.5.2  Contrast Sensitivity
A blank screen or a 20° spot of luminances  16, 24 or 32 cd m'2 was displayed five times for 
a duration of two seconds in a randomised sequence.  Each trial was repeated three times in 
a cycle.  The cycle was repeated at  10 minute intervals.
One or two control cycles were recorded before the systemic administration of the GluR5 
antagonist, LY382884 (50 mg/kg), via the femoral cannula over a period of approximately 
two minutes.
Data were then collected until a change in response occurred and recovery achieved, or 
until a change in response had occurred and for 40-60 minutes following this change (4-6 
cycles).
8.6  Optic Chiasm Stimulus Protocol
To test for changes in optic tract fibre activation a blank screen or a 20° spot of luminance 
32 cd m 2 was displayed five times for a duration of two seconds in a randomised sequence. 
Each trial was repeated three times in a cycle.  The cycle was repeated at 5 minute 
intervals.
104Several control cycles were recorded before vehicle or the GluR5 antagonist, LY382884 
(50 mg/kg), was systemically administered via the femoral cannula over a period of 
approximately two minutes.  Data were then collected for 30-40 minutes following 
injection.
8.7  SSC Stimulus Protocols
8.7.1  Iontophoresis visual stimulus and drug cycle protocol
5 repetitions of a 2 second visual stimulus, either a 35 cd m"2 spot of 20° visual space or 
horizontally moving bar (width 4°, length 20° and velocity 40° sec'2), was dispalyed at  10 
second intervals.  This was followed by  10-13 second ejections of ATPA, AMPA and 
NMDA at approximately 50 second intervals.  Drug ejections were of -35 nA to -120 nA. 
The cycle was repeated at 5 minute intervals.
Once stable control recordings were achieved, antagonist was continuously ejected using 
currents of -5 nA or by turning off the retaining current for two cycles.  Antagonist ejection 
was then ceased and recovery data were collected for 3 cycles.
8.7.2  Analysis
Habituation of visual response was calculated with the following calculation:-
105" number of spikes evoked during 4th  presentation'
L number of spikes evoked during 1s t presentation.
Thus the response to the 4th stimulus was expressed as a percentage of the response to the 
1st stimulus.
The change in habituation during antagonist ejection was calculated by expressing post­
ejection habituation as a percentage of pre-ejection control values.
8.7.3  Statistical Analysis
The most suitable means of analysis would be the Wilcoxon signed rank matched pairs test. 
The Wilcoxon test has been chosen for three reasons.  Firstly the data consist of matched 
pairs (ie before and after antagonist is administered).  Secondly, the data cannot be assumed 
to follow a normal distribution.  Finally the test can be applied to a small sample size.  Thus 
the appropriate non-parametric test is the Wilcoxon signed rank test.
The power of a test is the probability of avoiding a Type II error; if the test is not powerful 
there is a high chance of Type II error.  By their nature non-parametric tests are not as 
powerful as their parametric counterparts, thus necessitating larger sample sizes.
Preliminary testing therefore, will simply return a Type II error; the Null Hypothesis may 
be accepted when, in fact, it is invalid.  Although the Wilcoxon signed rank test can be used 
to test significance of small groups, six is the minimum number to which a two-tailed test
x100
106can be applied.  Therefore, for data sets containing less than six the Student t-test was 
applied.
8.8  Experimental Considerations
8.8.1  In Vivo
Although iontophoresis is useful to administer pharmacological agents locally to the cell 
being recorded from, it was not possible to determine the concentration of the drug in the 
extracellular environment in the current experimental arrangement.  For some agents where 
concentration determines selective receptor action it is necessary to employ agonists to 
receptors not directly under scrutiny to evaluate specific receptor interaction.  To clarify 
receptor selectivity future slice experiments confirming receptor involvement in synaptic 
transmission should be performed.  This type of experiment enables the application of 
drugs at known concentrations, thus the concentration-dependent action of agents can 
clarify the receptor type involved in responses.
Despite this disadvantage, in vivo recording does permit the observation of receptor 
involvement to physiologically pertinent stimuli in the intact animal.
8.8.2  In Vitro
Although slice preparations cannot be considered an intact system, they do have certain 
advantages over in vivo preparations.  Primarily, the necessity for anaesthesia for in vivo 
experiments is likely to affect neuronal responses as anaesthetics are centrally acting drugs.
107Brain slice recordings in the LGN also allow the possibility of separate retinal and cortical 
afferent stimulation (Turner & Salt,  1998).  This may allow more detailed determination of 
KAR involvement in visual processing in this structure.
8.8.3  Systemic Drug Administration
Iontophoresis is a valuable method for the observation of neuronal response to locally 
administered drugs, however as mentioned previously, the concentration of drug ejected 
cannot be determined.  The initial experiments involving the systemic injection of GluR5 
antagonist were designed to see if KARs would have any involvement in visual processing 
in the LGN.  The injection of the specified concentration of LY382884 ensured the 
concentration of drug in the neuronal environment that would selectively affect GluR5 
receptors.  The disadvantage of this method is that the drug will affect all GluR5 receptors 
in the brain.  Therefore, GluR5 receptors throughout the visual system, from the retina to 
the cortex, are affected by the injected drug and the specific affect of receptor interaction in 
the brain structure of interest is not possible to ascertain.
1089  Results
9.1  Systemic Injection and LGN Recording
Previous work has observed the involvement of  post-synaptic KARs in synaptic 
transmission (Cossart et al.,  1998;Li & Rogawski,  1998).  Additional observations suggest 
that as firing frequency increases, there is activation of post-synaptic KARs to produce a 
small, slow EPSC (Castillo et al,  1997).  Therefore a protocol using visual stimuli of 
increasing luminance was used to observe neuronal response to an increasing firing 
frequency of RGCs before and during GluR5 antagonist administration.
Averaged responses to visual stimulus of luminances  16, 24 and 32 cd m'2 were produced 
from peristimulus time histograms (PSTHs).  The area of the resulting histograms were 
calculated and compared before and at maximal effect of systemic injection of GluR5 
antagonist.
As mentioned previously, KARs are thought to modulate of GABAergic transmission 
(Clarkeetal,  1997;Min etal,  1999;Rodriguez-Moreno etal,  1997;Rodriguez-Moreno et 
al, 2000).  The centre-surround response observed in the LGN is due to the recruitment of 
GABAergic circuitry as stimulus size increases (Hubei & Wiesel,  1961 ;Sillito & Kemp,
1983).  A visual stimulus of increasing spot diameter was, therefore, used to attempt to 
produce the response and observe the effect of systemic GluR5 antagonist injection. 
Although centre-surround was not observed in the neurons from which the data were 
produced, the affect of systemic injection on increasing stimulus size was calculated. 
Wrapping responses to visual stimuli of spot diameters 5,  10 and 20° of visual space, and
109calculating histogram area of the responses determined this effect.  The PSTH areas were 
then compared before systemic injection and during the maximal effect of the GluR5 
antagonist LY382884.
Preliminary data from 3 cells showed that the time points where maximal drug effect was 
seen were 20 minutes after injection for spot diameter, and 30 minutes for luminance 
recordings (figure 7A and B).  At the dose of antagonist injected (50 mg/ kg), the brain 
levels of the drug can only reach concentrations affecting KARs.  Therefore, the maximal 
effect will only be due to LY382884 acting at KARs.  The times at which maximal affect 
was observed were consistent in all experiments and were used to determine changes in 
visual response in subsequent experiments in the LGN.  The time points are at different 
times for analysis of diameter and luminance because these stimuli were shown alternately 
in the same experiment.
The preliminary data also demonstrated that the systemic injection of GluR5 antagonist, 
LY382884, into the femoral vein reduced the visual responses to all stimuli (figure 8A and 
8B) with neurons usually recovering to control values within 70-80 minutes (figure 7).  The 
reduction of neuronal responses was similar for all stimuli presentations.  Values are 
summarised in Table  1.
All 5 neurons showed a marked decrease in visual response to 48.7±8.24% of control 
values and to ensure that this reduction was due to specific drug affects, vehicle injections 
where carried out in the same way.  Systemic administration of vehicle alone did not reduce
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Figure 7.  The effect of GluR5  antagonist injected systemically.  A) The graphs show 
responses to luminance levels of (i) 16 cd m-2 (ii) 24 cd m-2 (iii) 32 cd m-2.  Responses 
are  expressed  as  the  percentage  of control  responses  prior  to  drug  injection,  n  =  3. 
Stimulus cycles were repeated at  10 minute intervals with a maximal antagonist effect 
at 30 minutes post-injection.  B) The graphs show responses to spot diameters of (i) 5° 
(ii)  10° (iii) 20 ° of visual space,  n = 3.  Stimulus cycles were repeated at  10 minute 
intervals  with  a  maximal  antagonist  effect  at  20  minutes  post-injection.  Values  are 
given in Table 1.A)
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Figure 8. A)  The histograms represent visual responses to luminance levels  16, 24 and 
32  cd  m-2  after  antagonist  injection,  expressed  as  the  percentage  of control  values 
(n=3).  B)  visual responses to spot diameters 5,  10 and 20° after antagonist injection, 
expressed as the percentage of control values (n=3). The graphs show data at the point 
of maximal  antagonist effect.  (At 20  minutes  for spot diameters  and  30 minutes  for 
luminance levels)  Values are given in Table 1.visual responses to a stimulus of 20° of visual space (92.4±9.61%, n=2) (figure 9) thus 
demonstrating that the effects on visual response are produced by the antagonist and not by 
indirect influences on the cardiovascular system.
Measurements from the optic chiasm following either drug or saline application resulted in 
no change in visual responses (antagonist  100.4±8%, n=2; vehicle  103.5±9.71%, n=3) 
(figure 9).  These observations indicate that the effects observed during LY382884 
injection in the LGN are a product of GluR5 blockade in the LGN or another part of the 
brain influencing the processing of retinal input in the LGN rather drug influence on retinal 
processing.
Table 1
Stimulus
% decrease 
in control 
values
n
Luminance 16 cd m'2 46.6±2.30 3
24 cd nf2 59.6±10.97 3
32 cd m'2 52.2±2.04% 3
Spot Diameter 5° of visual space 58.2±8.94 3
10° of visual space 54.0±21.78 3
20° of visual space 52.3±12.31 3
Data are expressed as mean±sem.
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Figure 9.  Histogram showing changes in visual responses recorded in the LGN during 
systemic LY382884 injection (48.7±8.24% of control values, n=5) and vehicle injection 
(92.4±9.61% of control values, n=2).  Thus illustrating the reduction of visual response 
in  the  LGN  is  due  to  drug  affect.  Neither drug nor vehicle  injection  reduced  visual 
responses recorded at the optic chiasm (100.4±8.00%, n=2  and  103.5 ±9.71%, n=3  of 
control respectively)9.2  Iontophoresis in the SC
Initial studies on visual responses and response habituation were conducted using the 
NMDA antagonist D-AP5 to demonstrate reliable iontophoretic recordings from the rat 
SSC.  The ejection of the NMDAR antagonist during presentation of visual stimuli, resulted 
in the reduction of visual responses in 8 out of 17 neurons (73.5+4.45% of control values) 
(figure  10A).  Of the remaining cells, a further 8 remained D-AP5 resistant (99.4±2.50%), 
while  1   neuron displayed an enhanced response to visual stimuli (162.41+5.11%). 
Heterogenous changes in response habituation also occurred during D-AP5 ejection (figure 
10B).  5 cells displayed an increase in habituation (130.3+10.61%), 9 cells displayed 
decreases (63.1+5.11%) and 3 cells remained unchanged (100.8+1.98%).
The results are comparable to previous work which has shown that visual response in a 
proportion of SGS neurons of the cat is reduced by NMDAR antagonists, while some 
remain ‘AP5-resistant\ and some responses may be slightly enhanced (Binns and Salt,
1994).  Moreover the same study by Binns and Salt (1994) also revealed that these results 
were achieved during antagonist ejections at currents that would selectively block NMDA- 
mediated responses.  These findings demonstrate that the technique of iontophoresis was 
carried out sufficiently well to accept those results collected during ejection of LY382884.
To determine direct KAR contribution to synaptic transmission between RGCs and 
collicular neurons, the GluR5 antagonist was iontophoretically administered whilst neuronsA)
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Figure 10. The NMDA antagonist causes heterogeneous effects on visual responses and 
response habituation.  A) Visual responses were reduced (73.5%±4.45, n=8), increased 
(162.41%,  n=l)  or  remained  D-AP5-resistant  (99.4%±2.50,  n=8).  B)  Response 
habituation  was  reduced  (63.1%±5.11,  n=9),  increased  (130.30%±10.61,  n=5)  or 
remained D-AP5-resistant (100.8%±1.98, n=3).  Student paired t-test,  *<0.05,  **<0.01, 
***<0.001, NS=not significant.were subject to visual and glutamate receptor agonist stimuli (figure  11).  Application of 
the GluR5 antagonist LY382884 to SSC neurons produced reversible, specific effects on 
visual responses and response habituation, without affecting agonist responses (figure  11).
From the peri-stimulus time histograms collected, data for averaged visual responses 
(figure  12A) and responses to drug ejection were calculated as the area for the histograms 
in each cycle.  Data collected during antagonist ejection were then expressed as a 
percentage of the control data collected prior to ejection.
Response habituation data were once again analysed as PSTHs (figure  12B), and the 
histogram area of the  1st and 4th responses to visual stimulus was calculated.  The 
calculation stated previously was then applied to the data to determine the percentage 
reduction of visual response.  This response habituation was compared before and after 
GluR5 antagonist ejection.
A change in visual response and response habituation of ±15% was considered to be due to 
antagonist affect, as the variation in control responses to stimuli prior to antagonist ejection 
was typically well below this value (±15% represents 2 standard deviations from control 
response values).  Using this criterion data were separated into one of three groups: 
increase in response, decrease in response, or no change in response.
Organising the results in this way it appeared that the iontophoresis of LY382884 caused a 
heterogeneous effect on both visual responses and response habituation.  Figure  13 A
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Figure  11.  PSTH  recorded  from  a  single  SSC  neuron  showing  response  to  5 
presentations of visual stimuli followed by ATPA, NMDA and AMPA responses.  The 
example  illustrates  a  selective  reduction  in  both  visual  responses  and  response 
habituation without affecting agonist responses, thus demonstrating the selective effect 
of LY382884.A) ^ 3 8 2 8 8 4 ^
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Figure  12.  PSTHs  showing  the  effect  of LY382884  on  A)  visual  response  and  B) 
response  habituation  before,  during  and  after  antagonist  ejection.  The  example  is 
recorded from a single SSC neuron demonstrating A) an increase in visual response and 
B) a reduction in response habituation between the 1st and 4th response.shows that visual response could increase (127.8+5.2%, n=7), decrease (68.7+2.86%, n=l 1) 
or remain unchanged (99.6+2.02%, n=13) with respect to control values during the ejection 
of GluR5 antagonist.  Similarly response habituation also demonstrated increases 
(118.8+2.52%, n=7), decreases (58.8+7.06%, n=13) and no change (102.7+1.79%, n=10) 
from control values (figure  13B), however, these changes were not correlated with changes 
in visual response (R2=0.0235) (figure  13C).
The population distribution plots for both visual response and response habituation 
demonstrate non-normal distributions (figure  14).  In the case of visual responses three 
clear populations of responses are apparent, corresponding to increase, decrease and drug- 
resistant cells (figure  14A).  Whilst not as clear in the case of response habituation, multiple 
populations can be discerned, although the boundaries between the groups that increase and 
were drug-resistant are more ill-defined than in the case of visual response (figure  14B).
9.3  In vitro Patch Clamp
9.3.1  Agonist Experiments
The intrinsic circuitry of the SSC causes some difficulty when trying to show the effects of 
receptor modulation on separate excitatory or inhibitory input onto neurons within the SSC. 
To overcome the problem of recording a compound EPSC/IPSC response it was necessary 
to use pharmacological tools to isolate the initial fast EPSC and slower IPSC responses.
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Figure  13. The GluR5 antagonist causes heterogeneous effects on visual responses and 
response habituation.  A) Visual responses were reduced (68.7%±2.86, n=ll), increased 
(127.8%±5.20,  n=7)  or  remained  LY382884-resistant  (99.6%±2.02,  n=13).  B) 
Response habituation was reduced (58.8%±7.06, n=13), increased (118.8%±2.52, n=7) 
or  remained  Ly382884  resistant  (102.7%±1.79,  n=10).  C)  Correlation  showing  the 
affect  of LY382884  on  visual  response  did  not  correlate  with  observed  affects  on 
response habituation (R2=0.0235,n=28).  This indicates visual responses and response 
habituation  are  mediated  via  different  mechanisms.  Student  paired  t-test,  *<0.05, 
**<0.01, ***<0.001, NS=not significant.A)
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Figure 14 A). Distribution of visual responses following LY382884 iontophoresis 
(n=31). Normal distribution is shown in blue. Responses in the SSC were non-normal, 
demonstrating at least three clear categories -  decreased response, increased response 
and LY382884 insensitive groups. Bin size = 10%. B). Distribution of response 
habituation following LY382884 iontophoresis (n=31). Normal distribution is shown 
in blue. Cellular responses in the SSC were non-normal. Bin size = 10%.With the aid of GABAa and GABAb receptor antagonists (bicuculline and CGP55845A 
respectively) it was possible to isolate the EPSC response in order to measure effects of 
compounds on the excitatory, retinal input to the SSC (figure  15 A).
In order to measure changes caused by effects on the local inhibitory transmission, a 
cocktail of glutamate receptor antagonists were applied to the slice preparation.  D-AP5, 
GYKI52466, CPPG and LY393053 were administered to block NMDA, AMPA, mGlu4, 6, 
7 and 8 (Group III), and mGlul, 2, 3 and 5 (Group I and II) respectively, leaving clear IPSC 
responses (figure  15B).  From these isolated responses it was then possible to observe 
changes in excitatory input or local inhibitory input onto SSC neurons.
Patch clamp recordings from collicular slices with intact retinal input were subsequently 
used to investigate neurotransmitter effects within the SSC. A fifteen minute application of 
the specific AMPA antagonist GYKI52466 dramatically reduced the EPSC amplitude to 
14.10% of control (figure  16), demonstrating that the majority of excitatory transmission to 
SSC neurons is mediated via AMPARs.
To examine the possible modulation of the AMPAR-driven excitatory input by the 
activation of GluR5 receptors ATPA was then applied to the slice preparation.  Application 
of the GluR5 agonist ATPA resulted in a dose-dependent reduction of EPSC amplitude 
(figure  17), as well as a dose-dependent increase in inward current (figure  18).
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Figure  15.  The  isolation of direct excitatory  input and  local  inhibitory  input  into  the 
SSC.  Waveform-averaged  (n=6)  whole-cell  EPSCs  in  response  to  optic  tract 
stimulation A) before (black) and during (red) administration of GABAa and GABAb 
antagonists and B) before (black) and after (blue) administration of AMPA, NMDA and 
mGluR antagonists.s
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Figure  16.  Data  recorded  from  a  single  neuron  showing  that  the  addition  of  the 
AMPAR  antagonist,  GYKI52466,  reduces  the  EPSC  amplitude  dramatically  (in  this 
case by 85.9%).  This indicates that the majority of the excitatory transmission to SSC 
neurons is mediated via AMPARs.A) 160
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Figure 17. Affect of increasing concentrations of ATPA on EPSC amplitude. 
A)Application of ATPA results in a dose-dependent reduction of EPSC amplitude. 
Concentrations of ATPA used were luM (diamonds, n=2), 2uM (squares, n=5), 3uM 
(triangles, n=6), 5uM (crosses, n=3) and lOuM (circles, n=2). ATPA application is 
indicated by shaded bar.  B)  ATPA reduces EPSC amplitude in dose-related manner. 
Concentration response curve obtained for the action of ATPA (1-1 OuM) on synaptic 
response. Points are mean±sem (n=2-5). From the dose-response curve the calculated 
EC50 value is 2.7±0.34uM.A)
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Figure  18. Affect of increasing concentrations of ATPA on holding current (mA). A) 
Application of ATPA results in a dose-dependent increase in inward current, with low 
drug  concentrations  having  little  affect.  Concentrations  of  ATPA  used  were  luM 
(diamonds, n=2),  3uM  (squares, n=3),  5uM (triangles, n=3) and  lOuM  (crosses, n=2). 
ATPA application  is  indicated by  shaded bar.  B)  Application  of the  KAR agonist, 
ATPA  (l-10uM,  n=2-6),  causes  a  dose-related  increase  in  inward  current  which  is 
significant with the application of 5uM ATPA but not significant during application of 
2uM or 3uM ATPA.Although the GluR5 agonist is relatively selective, it is possible that ATPA may able to 
activate AMPARs at the higher concentrations used (Clarke et al.,  1997).  Having 
established that AMPARs were responsible for most of the excitatory transmission (figure 
16) further investigation into these observations was required.
To determine whether ATPA produced its effects via AMPARs or GluR5, 3pM and 5pM 
ATPA were applied to the slice preparation firstly alone and subsequently in the presence 
of the AMPAR antagonist, GYKI52466.  These experiments revealed no significant 
difference in the reduction of holding current with 3pM ATPA in either set of experiments 
(figure  19A) (0.5±0.81  pA, n=5 without AMPAR block, -13.7±6.1  pA, n=6 with AMPAR 
block).  In contrast, the application of 5pM ATPA without GYKI52466 perfusion resulted 
in a significant increase in recorded inward current (-37.5±13.72 pA, n=3) which was 
abolished following application of GYKI52466 (-0.5 pA, n=l).  This demonstrates that the 
generation of an inward current during ATPA perfusion was mediated via AMPARs (figure 
19B).
The concomitant reduction in EPSC amplitude remains apparent even during perfusion of 
the AMPAR antagonist (figure 20).  There is indeed no significant difference between 
EPSC reduction before (44.6±6.12% of control, n ^ ) and during GYKI52466 
administration (47.2±5.90% of control, n=5).  These data support the suggestion that the 
reduction of EPSC amplitude is a product of a GluR5-specific effect of ATPA.
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Figure  19.  High  concentrations  of ATPA  cause  an  inward  current.  A)  There  in  no 
significant change  in holding current produced by 3uM ATPA,  however,  5uM ATPA 
results  in  a  significant  increase  in  inward  current  which  is  blocked  by  the  AMPAR 
antagonist.  This  demonstrates  that  increases  in  the  inward  current  with  high 
concentrations  of the  agonist are due to the  affect of ATPA on AMPARs rather than 
KARs.  B) Time course showing affect of AMPAR block on holding current following 
application of 5uM ATPA.A) B)
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Figure 20.  ATPA  reduces  EPSC  amplitude both with and without AMPAR block by 
GYKI52466.  Waveform averages (n=6) representing the reduction in EPSC due to the 
application of 3uM ATPA.  Averages are taken before (black) and during (red) ATPA 
application, without AMPAR block (A)  and with AMPAR block (B).  C) In both the 
absence and presence of the AMPAR antagonist, 3uM ATPA reduces EPSC amplitude 
to 44.6±6.12% and 47.2±5.90% of control values respectively.  This demonstrates that 
reduction of EPSC is due to the activation of GluR5-containing KARs.  Student paired 
t-test, *<0.05, ***<0.001For the majority of the in vitro experiments 2pM ATPA was used because there was less 
effect of this concentration on the holding current than 3pM ATPA (figure  18) while the 
amplitude of EPSC reponses was also significantly and reversibly reduced to 53.7±10.96% 
(n=5) of control values (figure 21).
In order to suggest a possible location of the GluR5 receptors at the synapse a paired pulse 
protocol was employed throughout the in vitro recordings.  Figure 22 shows that prior to 
the addition of ATPA (concentrations 2-10pM), there was paired-pulse facilitation in all 
except 2 of the  13 cells recorded.  The application of the agonist caused an increase in the 
mean paired ratio from  1.4±0.11  to  1.8±0.15 (p<0.001), where all cells except one 
displayed paired-pulse facilitation.
To investigate the affect of GluR5 receptors on intrinsic inhibitory input the cocktail of 
glutamate receptor antagonists was applied and a local stimulus used to activate local 
intemeurons.  This resulted in the production of isolated IPSC responses (figure  15B) the 
amplitude of which did not change significantly during 2pM ATPA perfusion (figure 23: 
96.9± 10.87% of control, n=6).
It is observed that stimulating the optic tract input into the SSC results in the generation of 
a compound EPSC/IPSC response (figure  15).  This suggests that the retinal ganglion cell 
input activates both excitatory and inhibitory transmission onto the same cell 
simultaneously.  The final set of experiments using the GluR5 agonist was designed to test 
whether the activation of GluR5 receptors affects both the direct excitatory input
131..W'"'--
041221.3
20 pA
50 ms
B) C)
140 
120 
o  100
S  80
• >  
a*  4 0
20
0
2uM ATPA
♦  ♦ ♦  • E P S C  a m p litu d e
A   ’  A I
1  3   5   7  9   11  13  15  17  19  21  2 3  25 2 7   2 9 
time (minutes)
Figure 21.  ATPA reversibly reduces EPSC amplitude.  A) Waveform-averaged (n=6) 
whole-cell EPSCs in response to optic tract stimulation before (black), during (red), and 
after  (blue)  perfusion  with  2uM  ATPA.  B)  Representative  plot  of EPSC  amplitude 
from a  single  cell  illustrating the  effect of ATPA  on excitatory synaptic transmission 
(the pink bar signifies ATPA administration).  Time points where waveform averages 
were  taken  are  indicated  by  arrows.  C)  2uM  ATPA  significantly  reduces  EPSC 
amplitude to 53.7±10.96% of control values (n=5). The data are displayed as mean±sem 
(p<0.05). Student paired t-test, *<0.05050106
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Figure  22.  ATPA  causes  an  increase  in  paired  pulse  ratio.  A)  Waveform  averages 
illustrating  paired-pulse  responses  before  (black)  and  after  (red)  2uM  ATPA 
application.  B) Scaling the responses to the first EPSC under control conditions shows 
that ATPA administration increases paired-pulse ratio.  C) ATPA reversibly increases 
paired-pulse  ratio  (n =  13;  P  < 0.001).  D) Under control  conditions  the paired-pulse 
ratio differed from cell to cell, with 2 out of 13 cells exhibiting paired-pulse depression 
and the remaining 11 showing paired-pulse facilitation. In all except 1   of the cells tested 
application of ATPA  (2-10uM)  increased the paired pulse ratio.  Student paired t-test, 
* * * < 0.001control  2uM ATPA  Recovery
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Figure 23. Effect of 2uM ATPA on IPSC amplitude.  A) 2uM ATPA does not cause a 
significant change in IPSC amplitude.  B) Plot of IPSC amplitude over time.  The plot 
shows  that  IPSC  amplitude  remains  unchanged  with  the  application  of 2uM  ATPA. 
Each  point  represents  an  average  of  six  evoked  responses.  Data  is  displayed  as 
mean±sem. Student paired t-test, NS=not significant.from the retina and the excitatory RGC input onto the local intemeurons, thus also 
influencing inhibitory transmission via an indirect route.
Neither GABAR nor glutamate receptor antagonists were applied which left the compound 
EPSC/IPSC responses intact.  During application of 2pM ATPA in the perfusate, both 
excitatory and inhibitory components of the compound responses were reduced 
(50.8±6.17% of control and 58.3± 17.77% of control respectively, n=5) (figure 24).  These 
data support the hypothesis that GluR5 receptors may be located presynaptically at both the 
RGC terminals onto SSC neurons and RGC terminals onto inhibitory intemeurons of the 
SSC.
9.3.2  Histology and Confocal Microscopy
To enable cell morphology to be examined following application of ATPA, the internal 
solution of the patch electrodes included 0.1% biocytin. Given the differences in cellular 
responses recorded in vivo, this approach was to enable cells to be subsequently analysed to 
determine a correlation between certain response types (increase, decrease or drug resistant) 
and morphological characteristics of SSC neuron subtypes. A selection of neurons from 
which recordings were made are shown in figure 25, although ultimately this method was 
not required as all cells behaved in a similar way after agonist application and therefore 
analysis of cell morphology not undertaken.
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Figure 24. Affect of 2uM ATPA on evoked compound EPSC/IPSCs.  A) i) Waveform 
averages  illustrating compound EPSC/IPSC responses before (black)  during (red)  and 
after (blue)  2uM  ATPA  application,  ii)  Overlay  of responses  before  and  during drug 
application. B) Representative plot of EPSC amplitude from a single cell illustrating the 
effect  of  ATPA  on  excitatory  synaptic  transmission  (the  bar  signifies  ATPA 
administration).  Time  points  where  waveform  averages  were  taken  are  indicated  by 
arrows.  C)  2uM  ATPA  significantly  reduces  EPSC  amplitude  to  53.7± 10.96%  of 
control values (n=5). The data are displayed as mean±semStudent paired t-test, *<0.05Figure  25.  A  representative  selection  of confocal  images  of biocytin-  filled  SSC 
neuronss recorded from in vitro slice preparations.  The dorsal surface of the SC lies to 
the top left comer of each image.  A) putative wide-field projection neuron.  B) putative 
narrow-field  projection  neuron.  C)  putative  stellate  GABAergic  intemeuron.  D) 
putative horizontal GABAergic intemeuron.9.3.3  Antagonist Experiments
The initial in vivo experiments all employed the GluR5 antagonist to reveal a function of 
the receptor subunit in the SSC and LGN.  For this reason it was logical to apply a GluR5 
antagonist during in vitro experiments.  The antagonist LY382884 was not used in the in 
vitro experiments, however, because of its limited supply, therefore, the newer compound, 
UBP296 was administered in its place.
Firstly the GluR5 antagonist was applied whilst recording EPSC responses evoked by 
stimulating the optic tract input to the SSC.  During recording  lOpM UBP296 was 
administered in the presence of GABA antagonists but did not effect responses significantly 
after a ten minute perfusion (88.7±2.60% of control, n=3) (figure 26A).  Figure 26B 
illustrates that, although some rundown of response is apparent, EPSC amplitude remained 
relatively unchanged throughout the experiments when results were pooled from three cells.
The less selective AMPA/KAR antagonist, NBQX was also applied in the presence of 
glutamate antagonists.  This was to test the effect of the non-selective KAR block on 
inhibitory transmission.  As with the application of lOpM UBP296, a  10 minute perfusion 
of lOpM NBQX did not significantly affect the amplitude of locally evoked IPSC 
responses (140.5±25.79% of control, n=4) (figure 27).
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Figure 26.  Effect of lOuM  UBP296 on EPSC amplitude.  A) Histogram to show that 
lOuM  UBP296  does  not  significantly  affect  EPSC  amplitude  (88.7±2.60%,  n=3).  B) 
Plot  of  mean  EPSC  amplitude  over  time.  Each  point  represents  the  average  of  3 
experiments in which six evoked responses were averaged and the EPSC amplitude was 
calculated  and  normalised  to  an  initial  value.  Results  are  displayed  as  mean±sem. 
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Figure 27. Affect of lOuM NBQX on IPSC amplitude.  A)  lOuM NBQX does not cause 
a significant change in IPSC amplitude.  B) Plot of IPSC amplitude over time.  The plot 
shows that IPSC  amplitude remains unchanged with the  application of lOuM NBQX. 
Each  point  represents  an  average  of  six  evoked  responses.  Data  is  displayed  as 
mean±sem, n=4. Student paired t-test, NS=not significant.Because UBP296 had no effect when applied alone, experiments were undertaken to 
attempt to reverse the action of ATPA on EPSC amplitude.  Slices were preincubated with 
20pM UBP296 for 11  minutes prior to a ten minute perfusion of 2pM ATPA.  The 
application of ATPA caused a reduction of EPSC amplitude to 64.9±8.32% of control 
values (pO.OOl, n=3) (figure 28A), thus showing that ATPA retains the ability to reduce 
EPSC amplitude in the presence of the GluR5 antagonist.  The reduction of EPSC 
amplitude during UBP296 perfusion did not differ significantly from the decrease observed 
without preincubation with the antagonist (figure 28B).  Figure 26C and 26D illustrate the 
reduction of EPSC amplitude during the experiment both when results were pooled from 
three experiments and during recording from a single cell respectively.
The preincubation experiments were repeated replacing 20pM UBP296 with  lOpM NBQX 
(an AMPA/KAR antagonist).  Again, 2pM ATPA reduced EPSC amplitude (49.1±4.52% 
of control, n=2) (figure 29A).  The reduction of EPSC amplitude by 2pM ATPA in these 
experiments is comparable to that of 3pM ATPA in the absence and presence of AMPAR 
block (44.6±6.12% and 47.2±5.90% respectively), thus indicating that the addition of 
1  OpM NBQX does not affect the action of ATPA (figure 29B).
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Figure  28.  Effect  of 20uM  UBP296  on  the  reduction  of EPSC  amplitude  by  2uM 
ATPA.  A)  The histogram  shows  that 2uM ATPA  retains the ability to reduce  EPSC 
amplitude.  B) 2uM ATPA in the presence of 20uM UBP296 reduces EPSC amplitude. 
The magnitude of this reduction is not significantly different to the reduction observed 
in the absence of the antagonist.  C) Plot of EPSC amplitude over time. D) Data from a 
single  cell  showing  the  effect  of  20uM  UBP296  on  EPSC  amplitude.  Each  point 
represents  the  average  of  six  evoked  responses  where  the  EPSC  amplitude  was 
calculated  and  normalised  to  an  initial  value.  Results  are  displayed  as  mean±sem. 
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Figure  29.  The  effect  of NBQX  on  EPSC  amplitude  reduction  by  ATPA.  A)  The 
histogram  shows  that  NBQX  does  not  reverse  ATPA  reduction  of EPSC  amplitude 
which decreases to levels seen during 3uM ATPA and ATPA + GYKI52466 application 
(49.1±4.52%, n=2).  B) Plot of mean EPSC amplitude over time. Each point represents 
the  average  of 2  experiments  in  which  six  evoked  responses  were  averaged  and  the 
EPSC  amplitude  was  calculated  and  normalised  to  an  initial  value.  Results  are 
displayed as mean±sem. Student paired t-test, *<0.05, ***<0.001.10  Discussion
The data presented here provide the first functional evidence for kainate receptors in the 
rodent subcortical visual system.
10.1  In vivo data
10.1.1  Systemic administration of LY382884 reduces visual responses 
in the LGN
The injection of 50mg/kg LY382884 resulted in a 51.31 ±8.24% (mean±sem) reduction of 
visual responses to a stimulus size of 20° in LGN neurons which contrasts with vehicle 
injections which caused no change in visual responses (figure 9).  Results from these 
experiments demonstrated that the observed reduction by GluR5 antagonist was due to 
blockade of GluR5 KARs and was not as a result of a non-specific effect of the injection 
vehicle.
The reduction of visual responses after injection of the GluR5 antagonist and the 
subsequent recovery, suggests that the drug is acting at GluR5 KARs within the visual 
system.  These KARs could also be located in neuronal networks influencing LGN relay 
cell responses.  It is not possible to localise the drug effect on GluR5 receptors to any one 
part of the visual system during systemic administration as the compound would affect 
GluR5 receptors throughout the brain.  In addition, an explanation of possible mechanisms 
of action is not possible as GluR5 receptors have been associated with both the modulation 
of GABAergic transmission (Clarke et al.,  1997;Cossart et a/.,  1998;Frerking et al.,
1441998;Min et al.,  1999;Rodriguez-Moreno et al.,  1997;Semyanov & Kullmann, 2001), 
glutamatergic transmission (Rodriguez-Moreno & Sihra;Lauri et al., 2005;Kamiya & 
Ozawa,  1998) and postsynaptic EPSP generation (Swanson et al,  1996).
Therefore, systemic administration of a GluR5-selective concentration of LY382884 
(50mg/kg) establishes that KARs are involved in visual processing and effect LGN 
responses to visual stimuli (both spots of different size and contrast: figures 7 and 8), but 
does not reveal the mechanism by which these affects are achieved.
10.1.2  Systemic injection of LY382884 does not affect responses in the 
optic chiasm
Injection of GluR5 antagonist reduces visual responses recorded from the LGN, however, 
no change was observed in responses recorded from the optic chiasm (figure 9). This 
suggests that GluR5 KARs are involved in visual processing downstream of the eye.  These 
data do not, however, indicate the precise location of the receptors in the visual pathway, 
but provide some evidence that GluR5 receptors are able to influence visual processing 
within the LGN. The results do not eliminate the possibility that the antagonist is unable to 
cross the blood-retinal barrier (BRB) and, therefore, incapable of affecting receptors 
present in the retina.  The inability to pass the BRB gains further support from evidence 
that KAR function has been demonstrated in the retina (DeVries & Schwartz,
1999;Brandstatter et al.,  1997); data suggest that AMPARs mediate transmission via b2 
bipolar cells and KARs mediate transmission from photoreceptors via b3 and b7 bipolar 
cells, all of which are ‘OFF’ bipolar cells (DeVries, 2000).  Further experiments to clarify
145this issue could include the current method of systemic administration coupled with high- 
performance liquid chromatography (HPLC) analysis of retinal tissue to detect drug 
presence. Alternatively, tritiated compound could be administered and identified using 
either scintillation counting of retinal extracts or autoradiography of retinal sections.  The 
latter technique may also provide information on drug binding sites.
Constraints of time and compound availability (especially given the large doses required by 
this approach) limited the systemic administration studies, which could also have been 
conducted in the SSC.  However, iontophoresis enabled a more detailed characterisation of 
KAR function in the structures of the visual pathway.
10.1.3  In vivo iontophoresis of LY382884 produces heterogeneous 
effects in the SSC
Microiontophoresis enables drug delivery directly to the neuronal environment from which 
recordings are made.  Such an approach allows the in vivo characterisation of cellular 
responses to drug application within a very limited area, ideally affecting specific receptors 
in the immediate vicinity of the cell under investigation.
Iontophoretic recordings were attempted in both the LGN and SSC, although greater 
success was achieved in the SSC.  Lack of success in the LGN may have been due to the 
deeper location of the LGN in the brain; LGN recordings were less stable, whereas the 
more superficial location of the SSC may have led to improved recording stability.
146Within the group of observations from this set of experiments, it was clear that there were 
varied responses to the iontophoresis of the GluR5 antagonist LY382884; responses were 
seen to increase, decrease or remain antagonist-resistant.
These findings suggest that GluR5 is involved in modulation of both visual responses and 
response habituation in the SSC.
These data represent the first demonstration that GluR5 is physiologically functional in the 
SSC.  However, iontophoresis does not provide evidence for the location of these receptors 
or their mechanism of action.
Although iontophoresis permits drug delivery to a more specific location within the CNS 
than systemic administration, there are a number of limitations associated with this 
technique.  Whilst iontophoresis allows the application of a drug to the immediate cellular 
environment, this does not guarantee drug access to the receptor under investigation.  A 
number of factors must be considered, such as drug access to the recorded cell, cellular 
geometry (whether the cell and it’s dendrites are compact or widespread) and receptor 
location on or around the recorded cell (Stone,  1985).  These factors mean that the exact 
placement of the electrode with respect to the cell soma and dendritic arbour may affect the 
result obtained if the receptors are differentially located on the cell.
Many cells of the SSC have large somas and an extensive dendritic arbour (fig 25A and B) 
(Hilbig et a/., 2000), and these factors could account for the heterogeneous results obtained.
147For example, were GluR5 to be found on the dendrites and the electrode placed near the 
soma, little effect of the antagonist would be observed whilst recording from a cell with an 
extensive dendritic arbour. However, if GluR5 is located near the soma (or the recording is 
made from a smaller cell) an effect would be seen (fig 25C and D).
The finding that changes in visual response and response habituation were not correlated 
may suggest that these effects are mediated via different mechanisms.  Potential 
mechanisms by which these results may have arisen are discussed in more detail below.
10.1.3.a  Postsynaptic GluR5 kainate receptors
The results observed from in vivo iontophoresis could be explained by a postsynaptic 
GluR5 location. Evidence for postsynaptic KARs comes from a number of sources.
In some instances KAR-mediated EPSCs are negligible in single evoked responses and are 
only observed during high frequency stimulation (Castillo et al.,  1997;Cossart et al.,  1998; 
Frerking et al.,  1998;Li & Rogawski,  1998).  However, a small KAR-mediated component 
in recorded EPSCs has been produced in response to single stimuli at sensory inputs into 
the spinal cord (Li et al.,  1999), in somatosensory layer IV cortical neurons (Kidd & Isaac,
1999)  and cerebellar Golgi cells (Bureau et al, 2000).  This evidence along with the 
observation that KARs contribute to EPSCs in CA1  intemeurons (Cossart et al., 
1998;Frerking et al.,  1998) suggests that KARs could be located at postsynaptic sites on 
intemeurons within the SSC.  Here they may contribute to the generation of EPSCs and 
subsequent GABA release onto SSC neurons.  The blockade of these receptors could, 
therefore, lead to an indirect increase in visual response or a reduction in response
148habituation due to the disinhibition of GABAergic transmission.  A postsynaptic location at 
the RGC-SSC neuron, however, may result in the reduction of visual responses during 
GluR5 block.
KAR-mediated EPSC/Ps appear to be slower and smaller than AMPAR-mediated 
responses during both agonist application and synaptically released glutamate (Castillo et 
al.,  1997;Cossart et al.,  1998).  For this reason it has been suggested that postsynaptic 
KARs may play a role in the integration of excitatory input to enhance synaptic response of 
postsynaptic neurons (Frerking and Ohliger-Frerking, 2002).
The location and involvement of KARs in postsynaptic transmission in other areas of the 
CNS may suggest a similar scenario occurs in the SSC, with the heterogeneous responses 
obtained being a product of the limitations of the iontophoretic technique as discussed 
above.
10.1.3.b Modulation of presynaptic neurotransmitter release by GluR5
The results obtained from in vivo iontophoresis could be the result of presynaptic GluR5 
modulating glutamate or GABA release.
Glutamate release
There is convincing evidence that GluR5-containing receptor assemblies are mainly 
concerned with the modulation of input into the brain rather than mediating synaptic 
transmission (Clarke et al.,  1997;Cossart et al.,  1998;Frerking et al.,  1998;Min et al.,
1491999;Rodriguez-Moreno et al,  1997;Semyanov & Kullmann, 2001).  Furthermore, KAR 
involvement in the bi-directional modulation of excitatory synapses has been illustrated at 
MF-CA3 synapses in the hippocampus possibly via an autoreceptor that senses synaptically 
released glutamate (Lauri et al., 2001; Schmitz et al., 2001; Contractor et al., 2000).
Investigations into the underlying mechanisms of the bi-directional quality of KAR- 
mediated responses have led to the following suggestions.  The activation of KA- 
autoreceptors may cause an afterdepolarisation resulting in a transient increase in 
intracellular Ca2+ and thus increasing glutamate release probability with subsequent stimuli 
(Kamiya et al, 2002).  No link, however, has yet been found between these two events.
In contrast, the reduction of glutamate release may be due to presynaptic KARs.  The 
activation of these receptors has been shown to reduce transmitter release via the reduction 
of presynaptic Ca2+ influx (Kamiya & Ozawa, 2000).  The reduction of the Ca2+ 
conductance may come about from the inactivation of axonal Na+ channels, shunting of the 
presynaptic membrane or as a result of Ca2+ channel inactivation by membrane 
depolarisation (Kamiya & Ozawa, 2000).
This may explain the observation of both increases and decreases in visual response and 
habituation depending upon the receptor location at the synapses affected by the ejected 
antagonist.  If the antagonist affects an autoreceptor this may lead to reduction of glutamate 
release and frequency-dependent facilitation, whereas the block of presynaptic receptors 
may well result in the enhancement of synaptically released glutamate.
150Another possibility could be that KARs, which gate cation channels, would cause a 
reduction in neurotransmitter release if a KAR-mediated presynaptic depolarisation caused 
the inactivation of K+-channels.  This may result in the subthreshold depolarisation of the 
neuron terminal resulting in the enhancement of neurotransmitter release.  Therefore, 
antagonism of presynaptic KAR activation would again result in the reduction of KAR- 
mediated glutamate release, thereby reducing frequency-dependent facilitation.
In addition, increases in visual response during drug ejection may be due to the reduction of 
glutamate release at the retinal ganglion cell (RGC)-intemeuron synapse, which would 
result in the reduction of GABAergic transmission at the intemeuron-SSC neuron synapse. 
The converse result (i.e. a reduction of visual response) could also be due to antagonism of 
KARs reducing glutamatergic transmission at the RGC-SSC neuron synapse.  Also the 
reduction of glutamatergic transmission at this synapse may cause a reduction in 
habituation.  This would be owing to the disinhibition of the SSC neuron as a result of 
decreased activation of inhibitory intemeurons.
Both the reduction in visual response and increase in habituation may be attributed to a rise 
in glutamate release; blocking presynaptic KARs could relieve the inhibition of 
glutamatergic transmission that they may induce at the RGC-intemeuron synapse.  Such an 
action may produce a decrease in visual response due to the greater stimulation of 
GABAergic transmission at the intemeuron-SSC neuron synapse.  The effect on this 
pathway may also result in the observed increase in habituation.  However, blocking GluR5
151at the RGC-SSC neuron synapse may also increase glutamatergic transmission to produce 
an increase in visual response.
GABA release
Previous work has shown that GluR5 is involved in the inhibition of IPSCs (Clarke et al., 
1997; Clarke & Collingridge, 2004). It was thought that this reduction of IPSPs was a 
presynaptic phenomenon via an indirect mechanism, i.e. an increase in GABA release 
causing the activation of a presynaptic GABAb autoreceptor and the activation and 
subsequent desensitization of a postsynaptic GABAaR (Frerking et al.,  1999).  This would 
result in the shunting of the postsynaptic cell (Frerking et al.,  1999).  However, KA has 
been shown to reduce IPSPs via a GABA-independent mechanism (Fisher & Alger,  1984). 
In addition, the GluR5 agonist, ATPA, reduces IPSPs in the presence of either GABAaR or 
GABAbR antagonists (Clarke et al.,  1997; Clarke & Collingridge, 2004).  This suggests 
that the activation of KARs results in the direct reduction of GABAergic transmission and 
not via the modulation of GABAergic transmission by synaptically released GABA (Clarke 
et a!.,  1997; Clarke & Collingridge, 2004).  This evidence also indicates that the activation 
of KARs may cause the reduction of GABA release via a heterosynaptic pathway or by 
direct actions on presynaptic terminals.
Further work has indeed suggested the existence of two populations of KARs at 
hippocampal intemeurons the activation of which may be dependent on different glutamate 
concentrations (Rodrigeuz-Moreno et al., 2000).  The study proposes that low glutamate 
concentrations activate presynaptic KARs which reduce GABA release, whereas
152somatodendritic KARs (Devries & Schwartz,  1999) may increase intemeuronal firing 
(Rodrigeuz-Moreno et al., 2000; Fisher & Alger, 1984).
Thus the action of the GluR5 antagonist on SSC neuron activity may be dependent on 
which population of KARs are blocked.  For this reason it is possible that the GluR5 
antagonist, LY382884, may increase GABAergic transmission by acting at presynaptic 
KARs at the intemeuron-SSC neuron synapse and result in the reduction of visual response. 
An increase in habituation may also be the result of an increased GABAergic transmission 
at the intemeuron-SSC neuron synapse.
Alternatively KAR activation resulting in GABAergic transmission facilitation (Cossart et 
al., 2001; Mulle et al., 2000) may be due to the activation of somatodendritic receptors 
(Devries & Schwartz,  1999; Kidd & Isaac,  1999).  It is therefore, possible that blocking 
these KARs would reduce facilitation of GABAergic transmission at the intemeuron-SSC 
neuron synapse.  The resulting reduction of GABA release may subsequently lead to an 
increase in visual response.  A reduction of habituation may also be due to the reduction of 
GABAergic transmission at the interneuron-relay cell synapse.
10.1.4  ATPA response
ATPA was applied iontophoretically with the aim of selectively activating GluR5. The 
subsequent application of the antagonist LY382884 would then be expected to cause a 
reduction in this ATPA response.  It is, therefore, surprising that LY382884 failed to reduce 
ATPA-evoked responses, however, it is also acknowledged that ATPA is able to activate
153AMPARs (Clarke et al.,  1997).  In light of this information, the ATPA-evoked response is 
in all probability mediated by AMPARs.
The failure to reduce or block neuronal response to ATPA could be the result of KARs 
already being deactivated due to their rapid deactivation kinetics to ATPA and the 
subsequent activation of AMPARs (Chittajallu et al.,  1999).  Alternatively the responses to 
ATPA ejection may have been solely mediated by AMPARs; as the exact concentration of 
drug ejected is not possible to determine, ATPA may have been ejected at a high enough 
concentration to activate AMPARs.
Experiments where no difference between control and experimental conditions were 
observed may lead to the suggestion that GluR5 receptors are not involved in direct 
synaptic transmission between the RGCs and cells of the SC.  This could indeed be the 
case, however, other possibilities exist; a lack of effect of LY382884 on habituation and 
visual response may be explained by a lack of GluR5 subunits or functional GluR5- 
containing receptors influencing the cells recorded or any GluR5 subunits present may be 
located too far from the electrode to be affected by the antagonist.
The lack of antagonist effect on AMPA and NMDA responses demonstrates that 
LY382884 ejection currents were not great enough to cause a non-specific effect on all 
ionotropic receptors; higher ejection currents were previously shown to do so (data not 
shown).
15410.2  In vitro slice recording
To further characterise the location and possible mechanism of action of GluR5 in the SSC, 
whole-cell voltage clamp experiments were conducted in SSC slices.
Whilst isolating the structure from its native environment, and potentially removing the 
majority of connections from other brain regions, this approach is particularly advantageous 
for detailed characterisation of receptor function and local circuitry. This would therefore 
enable the question of pre- or postsynaptic GluR5 location to be addressed, because it 
removes the variability which is due to heterosynaptic activation.
10.2.1  Isolation of direct excitatory input and local inhibitory input into 
the SSC
As it is well known that SSC function is strongly influenced by extensive inhibitory 
circuitry involving local GABAergic intemeurons (Mize,  1992), it was important to 
dissociate the inhibitory input from the excitatory input. This enabled the study of the 
relative contribution of GluR5 to both excitatory input and inhibitory circuits within the 
SSC.
To isolate the excitatory component of the cellular response within the SSC, GABAa and 
GABAr antagonists were included in the perfusion medium to abolish inhibitory input 
(figure  15A). This resulted in an isolated EPSC, which reflected stimulated input from the 
optic tract.  Local  inhibitory input was isolated by addition of a cocktail of AMPAR,
155NMDAR and mGluR antagonists (figure  15B). This resulted in an isolated IPSC response, 
reflecting the contribution of local inhibitory interneurons.
10.2.2  ATPA reduces EPSC amplitude in dose-dependent manner
Initial studies of GluR5 in tissue slices used a low concentration of ATPA (lpM) as this has 
been shown to be GluR5-selective in the CA3 region of the hippocampus (Clarke et al.,
1997).  However, administration of such a low concentration resulted in no observed effect 
on EPSC amplitude.  It was therefore important to further investigate if this was a dose- 
dependent phenomenon. Application of lOpM ATPA resulted in a reduction of EPSC, but 
also resulted in a postsynaptic inward current. As previously described, KARs can be 
located postsynaptically (Castillo et a!.,  1997). Therefore, it was prudent to investigate 
whether the postsynaptic inward current was due to the activation of postsynaptic KARs. In 
addition, ATPA has been shown to activate AMPARs (Clarke et al.,  1997), therefore 
differentiating between the generation of inward current and EPSC reduction was vital, to 
determine whether these effects were mediated by the same or different receptor groups.
In order to determine which receptor groups may be involved a five point dose-response 
curve was constructed (figure  17B). The effect upon inward current was also evaluated 
(figure  18). From this data it was apparent that higher doses of ATPA (5-10pM) were 
responsible for the generation of postsynaptic inward current. Although the non­
competitive antagonist GYKI52466 may be used as a non-specific AMPAR/KAR 
antagonist (Palmer & Lodge,  1993; Donevan & Rogawski,  1993; Zorumski etal.,  1993), 
the compound can be used at concentrations selective for AMPARs, allowing investigation
156of KAR-mediated activity.  Therefore, to exclude AMPAR activity, it was essential to 
include GYKI52466 in the perfusate. Inclusion of GYKI52466 abolished the inward 
current, demonstrating that this effect caused by ATPA was mediated by AMPARs.  These 
findings are in agreement with previous studies in the CA1   and CA3 region of the 
hippocampus, where ATPA reduces excitatory synaptic transmission which is not 
associated with the generation of an inward current (Vignes et al.,  1998).  Also in 
agreement with the current data the application of ATPA concentrations higher than 2pM 
resulted in an inward current (Vignes et al.,  1998).
In view of the fact that ATPA was originally synthesized as a selective agonist for 
AMPARs (Lauridsen et al.,  1985), it is perhaps not surprising that ATPA displays activity 
at AMPARs.  What is unexpected is the concentration at which ATPA appears to activate 
AMPARs in this study.  In HEK293 expression systems a >6000-fold selectivity for KARs 
over AMPARs is observed (Clarke et al.,  1997).  In contrast, in this study using a native 
tissue preparation, effects of ATPA at AMPARs required only a 2.5-fold increase in ATPA 
concentration.
10.2.3  ATPA reduces EPSC amplitude both with and without AMPAR 
block by GYKI52466
3pM ATPA reduces EPSC amplitude by a similar percentage both in the absence and 
presence of GYKI52466 in the perfusate medium.  The reduction of responses during 
AMPAR block indicates that the lower concentrations of 2 and 3pM ATPA reduce EPSC 
amplitude solely by the activation of GluR5 KARs (figure 20).
157In the CA1   region of the hippocampus the activation of GluR5 appears to directly suppress 
inhibitory transmission (Clarke et al.,  1997).  However, research both in this and other 
areas of the central nervous system have revealed that the activation of KARs and GluR5 
subunits in particular is able to reduce excitatory input.  KARs appear to mediate a variety 
of actions including a presynaptic reduction of excitatory transmission within the 
hippocampus.
The activation of presynaptic KARs with the application of a higher dose of kainate (3pM) 
is able to cause a reduction of excitatory transmission at the mossy fibre-CA3 (MF-CA3) 
synapse (Kamiya & Ozawa, 2000).  The decrease in excitation is possibly the result of 
depolarisation of the presynaptic axon or terminal causing the inactivation of Na+-channels 
which leads to the block of action potential conduction and Ca2+ influx (Kamiya & Ozawa,
2000).  It was later shown that the presynaptic inhibition of excitatory transmission was 
GluR6-dependent (Contractor et al., 2000), however, the use of ATPA in a subsequent 
study, indicated that GluR5 subunits may indeed contribute to the depression of excitatory 
transmission at the MF-CA3 synapse and in the CA1  region of the hippocampus (Vignes et 
al.,  1998).
10.2.4  ATPA reversibly reduces EPSC amplitude
Application of 2pM ATPA reduces EPSC amplitude (at a concentration that does not 
generate an AMPA-mediated inward current) (figure  18A), and as such this KAR-specific 
concentration was used in subsequent experiments.
15810.2.5  ATPA causes an increase in paired pulse ratio
To investigate the location of the GluR5 receptor which causes the reduction in EPSC 
amplitude, a paired-pulse protocol was applied.  By administering paired stimuli, a 
difference between primary and secondary responses is indicative of a change in release 
probability from the presynaptic terminal, indicating the activation of a presynaptic 
receptor. In contrast, no change in paired-pulse ratio would lead to the conclusion that the 
reduction in EPSC is due to a postsynaptic receptor. In this instance the protocol indicated 
that the activation of GluR5 receptors in the SGS caused an increase in paired-pulse ratio 
(figure 22), thus increasing the paired-pulse facilitation observed prior to ATPA perfusion.
It has been postulated that paired-pulse facilitation may occur at synapes when some Ca2+ 
binding sites associated with the release machinery are already occupied.  This would 
reduce the requirement for further Ca2+ binding and also increase binding site affinity for 
Ca2+ at the same time (Thomson, 2000).  Ca2+ entry may depend upon the following 
conditions:  1) the depolarisation characteristics which differentially activate populations of 
Ca2+ channels; 2) Synaptotagmin expression which functions as a possible Ca2+ sensor and 
primes release mechanisms during the initial presynaptic action potential, thus increasing 
the pool of vesicles ready for release by subsequent action potentials; 3) Fusion of these 
vesicles may be dependent upon the Ca2+channels activated during depolarisation of the 
terminal.
159It is possible that the activation of presynaptic GluR5 receptors may lead to enhanced Ca2+ 
entry into the synaptic terminal through activated channels.  Thus the first depolarisation of 
the terminal during GluR5 activation may permit raised levels of Ca2+ entry leading to an 
enlarged pool of vesicles available and primed for exocytosis.
10.2.6 Locally evoked IPSCs remain resistant to ATPA administration
The administration of antagonists to all GluRs except KARs produces a locally-driven, 
isolated IPSC recorded in SSC neurons (figure  15B).  This response provides a useful tool 
to determine possible KAR involvement in the modulation of inhibitory input to the SSC.
There is strong evidence to suggest that KARs (Rodriguez-Moreno et al.,  1997;Cossart et 
al., 2001) and more specifically GluR5 receptors (Clarke et al.,  1997;Braga et al., 2003) 
can be located on GABAergic intemeurons and at GABAergic terminals to modulate 
intemeuron activation and modulate GABAergic transmission.  However, it is clear from 
the results observed with local stimulation of IPSCs that KARs are not located at sites on 
inhibitory interneurons in the SSC.  The lack of ATPA-mediated effect on IPSC amplitude 
(figure 23) indicates that KARs do not influence local GABAergic transmission in the SSC.
10.2.7 ATPA reversibly reduces compound EPSC/IPSC responses
It is known that retinal ganglion cells projecting to the SSC are able to produce excitatory 
responses followed by a GABAA-mediated inhibitory response in the SGS neurons (Lo et 
al.,  1998).  Figure 24A illustrates the compound response recorded in SGS cells.  The
160application of ATPA to the compound EPSC/IPSC causes a reduction of both components 
(figure 24B and C).  These results provide evidence that not only are GluR5 receptors 
located on direct excitatory retinal input to SGS neurons, they also may indirectly effect 
inhibitory input. The previous set of experiments demonstrates that GluR5 receptors are not 
involved in inhibitory transmission (see above), therefore, the observations from this later 
investigation strongly suggest that GluR5 receptors are present on excitatory input into the 
local inhibitory circuit.
10.2.8  Location of KARs determined by in vitro patch-clamp 
experiments
Taking into account the results from in vitro EPSC and compound EPSC/IPSC recordings it 
may be suggested that GluR5 is located presynaptically on excitatory retinal terminals 
(figure 30). Firstly the change in paired-pulse ratio indicates an alteration of vesicle release 
probability in the presynaptic terminal.  Secondly it was observed that both the EPSC and 
IPSC components of the compound response were reduced during GluR5 agonist 
application.  This would indicate that GluR5 receptors not only reduce excitatory 
transmission at inputs which drive responses in SSC neurons, but these receptors are also 
able to reduce glutamatergic transmission which drives inhibitory circuits within the SSC. 
Therefore, it may be reasonable to propose that GluR5 is primarily involved in the 
presynaptic modulation of glutamatergic transmission via the retinal input to the SSC.
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Figure 30. The  representation of a serial synapse in the SSC.  An increase in 
paired-pulse ratio seen during ATPA application indicates a change in 
neurotransmitter release probability.  Therefore, one can conclude that GluR5- 
containing receptors can be localised to a presynaptic site at excitatory retinal 
input into the SSC.10.2.9  Antagonist Pharmacology
NBQX is a competitive antagonist (Sheardown et al.,  1990) therefore it is possible that its 
influence can be overcome with a high enough concentration of agonist; competitive 
characteristics by their nature are reduced if enough agonist is used.  The lack of reversal 
by NBQX of ATPA-induced reduction of EPSCs (figure 29), therefore, could simply be a 
result of using a concentration of NBQX that is more selective for AMPARs than KARs. 
This could be further investigated by the use of increasing concentrations of NBQX to 
reverse EPSC reduction by 2 pM ATPA.
Similarly to NBQX, UBP296 is a competitive antagonist (More et al, 2004), and as such 
may require using a greater concentration in order to antagonise ATPA-mediated effects. 
The exact concentration would be dependent on the relative affinities of both compounds 
for the GluR5-containing receptor.  Additionally, the lack of UBP296 effect may be 
because ATPA is exerting its effect via an alternative KAR subunit, thus causing a response 
that will not be reversed by a selective GluR5 anatagonist (see Clarke and Collingridge, 
2002, 2004); ATPA has a far greater selectivity for GluR5 than for GluR6 or GluR6/KA2 
heteromers, but may demonstrate activity at the KAR subunits GluR7 and KA2, and 
AMPAR subunits (Kj values of 6-14 pM at GluRl-4) (Clarke et al,  1997).  This is 
possibility should not be excluded and could be investigated using a combination of 
antagonists if and when they become available; the administration of an antagonist with a 
greater selectivity for the GluR7 or KA2 subunits along with the GluR5 antagonist may 
well reverse the effect thus indicating that the reduction of excitatory transmission is 
mediated by GluR7 or KA2.  Thus far, however, there are no compounds which specifically
163interact with GluR7 or KA2 as neither of these subunits are able to form functional 
homomeric receptors (Ozawa et al.,  1998).
Consequently, the pharmacology involved in this investigation may preclude GluR6- 
mediated activation, nevertheless, GluR7 or KA2 activation must still be considered.  It is 
known that GluR7 subunits can form functional receptor assemblies (Schiffer et al.,  1997; 
Dingledine et al.,  1999) and have a higher affinity for ATPA than GluR6 subunits in 
recombinant expression systems (Clarke et al.,  1997).  In addition, binding studies 
demonstrate that ATPA has a similar affinity for both GluR7 and AMPAR subunits (Clarke 
et al.,  1997).  Although affinity for GluR5 subunits has been calculated as being 1000-fold 
lower than for AMPARs (Clarke et a!.,  1997), it appears that this may not be the case in the 
SSC.  The current investigation suggests that in the SSC slice preparation ATPA may have 
a greater affinity for AMPARs than that previously determined, therefore, it should not be 
assumed that affinity of ATPA for GluR7 subunits would be similar to reported values.  In 
light of this, it would be prudent to further investigate KAR subunit configuration in SCC 
neurons perhaps using the combined approach of whole-cell voltage clamp recording and 
subsequent PCR investigation of subunit expression (Lambolez et al.,  1992).
10.2.10  Retinal input and recruitment of input
The in vitro data presented here strongly indicate the presence of functional, presynaptic 
KARs at retinal terminals in the SSC.  Moreover, the role of these receptors appears to 
involve the reduction of glutamatergic transmission between RGC terminals and SSC 
neurons.
164Using these findings, it is now possible to propose an explanation for the heterogeneous 
observations of the in vivo iontophoresis of GluR5 antagonist in the SSC.  Firstly, data 
showing a reduction in visual response may be a result of the heterosynaptic increase of 
GABAergic transmission.  This could occur as a result of blocking GluR5 receptors at 
retinal terminals which would increase glutamatergic transmission at the RGC-intemeuron 
synapse and subsequently increase GABAergic transmission onto SSC neurons, causing a 
reduction in visual response.
Additionally a decrease in visual response due to antagonist ejection may be due to the 
increase in glutamatergic transmission from retinal input or descending cortical afferents of 
neighbouring receptive fields (RF2 in figure 31).  Topographically mapped retinal afferents 
and cortical afferents from area  17/VI  of the visual cortex may be located at the same 
GABAergic intemeuron (Rizzolatti et al.,  1974) which may influence centre-surround 
inhibition of an adjacent receptive field (RF) (Binns & Salt,  1997).  Depending on whether 
neighbouring receptive fields are activated by the same stimulus and the antagonist has 
access to receptors at retinal or cortical afferents from these receptive fields it is possible 
that antagonist ejection may cause a reduction in visual response.  This may occur because 
the antagonist causes an increase in glutamatergic transmission onto GABAergic 
intemeurons mediating centre-surround inhibition thus increasing GABAergic input to the 
relay cell and decreasing excitation of the recorded cell.
165The presence of topographically mapped cortical terminals at SSC neurons could also 
account for an increased visual response during antagonist administration.  It is possible 
that GluR5 receptors may also be located at these excitatory terminals.  The ejection of 
antagonist would cause an increase in excitatory transmission at these synapses and, 
therefore, an increase in visual response in the SSC neuron.  An alternative and more 
straightforward explanation for the increases in visual response would be that they are due
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Figure 31.  A circuit diagram illustrating the possible interactions between two 
adjacent receptive fields (RFs) in the SSC.  Red represents GABAergic pathways, 
red represents glutamatergic pathways.  Details of the network and consequences 
of activations are given in the text.to the increase in glutamatergic transmission at the RGC-SSC neuron synapse during 
GluR5 antagonist ejection.
At the RGC-SSC neuron synapse it is feasible that GluR5 may operate as a presynaptic 
autoreceptor.  The activation of the receptor would lead to a reduction in repeated responses 
(response habituation) as has been suggested for Group III mGluRs (Cirone & Salt, 2001). 
An antagonist would, therefore, reduce GluR5 activity and thus cause a reduction of 
response habituation.  Conversely an increase in response habituation could be achieved by 
the antagonism of presynaptic autoreceptors at the RGC-intemeuron synapse, resulting in 
an increase in glutamatergic transmission onto GABAergic intemeurons.  This would 
subsequently increase GABA transmission at the intemeuom-SSC neuron synapse and 
cause the activation of presynaptic GABA bRs, which are known to play a part in response 
habituation in the SSC (Binns & Salt,  1997).
10.2.11  Comparison of in vivo antagonist versus in vitro agonist
The desensitisation of both native and recombinant GluR6 KARs to kainate and glutamate 
appears to be both rapid and concentration dependent (Patemain et al.,  1998).  In addition, 
recovery from such desensitisation is slow.  Moreover, the calculation of a half-inactivation 
value of 2.8pM coupled with in vivo extracellular glutamate concentrations of around 3pM 
(Lerma et al.,  1986), suggests that approximately 50% of KARs are desensitised in native 
tissue under physiological conditions.  These data suggest that even small variations in 
glutamate concentration may alter the availability of KARs for activation; at times of 
exposure to higher concentrations of glutamate, such as during epileptiform activity or
168ischemia (Attwell & Mobbs,  1994).  This would have implications for the role of KARs in 
the modulation of neuronal excitability, such that at high glutamate concentrations KAR 
function may become compromised due to desensitisation thus curtailing normal KAR- 
mediated regulation of synaptic transmission.
The small overlap observed during activation-inactivation studies indicates the existence of 
a small  ‘window current’ (Patemain et al.,  1998).  This is a period of steady state receptor 
activation which is maintained providing the agonist concentration remains constant (Hille,
2001).  The demonstration of this phenomenon for GluR6 activation-inactivation indicates 
that at physiological concentrations of ambient glutamate, it is entirely possible that a 
fraction of native KARs would remain activated.  This would go some way to explain why 
in vivo iontophoresis of antagonist results in the alteration of responses, whereas in vitro 
preparations often appear to be antagonist-resistant, but antagonist may reverse agonist 
effects.
16911  Conclusions
Taken as a whole the data presented here suggest that KARs are present in the rat SSC and, 
moreover, have a role in normal visual function.
Systemic application of GluRS antagonist was found to produce a reduction in visual 
responses in the LGN. This reduction was independent of spot size or contrast of the 
stimulus, suggesting that GluR5 KARs do not contribute to the transmission of contrast 
sensitivity or centre surround information. Instead, GluR5s may play a gross modulatory 
role in responses recorded in the LGN.  The possibility of a retinal GluR5 contribution to 
alterations in LGN responses was precluded, as recordings from the optic chiasm following 
systemic application of the antagonist remained unchanged.
Iontophoresis in the SSC demonstrated that GluR5 has a role in both visual processing and 
response habituation. However, due to the nature of microiontophoresis it was difficult to 
clearly classify the effects of the compound. Heterogeneous responses to antagonist 
application were observed in both visual responses and response habituation, and these 
effects were not seemingly correlated. The intrinsic circuitry of the SSC may be responsible 
for these varied results, with GluR5s located pre- or post-synaptically at glutamatergic or 
GABAergic terminals. Whilst GluR5s were clearly involved in visual processing in the 
SSC, their exact location and mechanism of action could not be determined.
Patch clamp studies using SSC slices further elucidated the role of GluR5 in synaptic 
transmission. Using an agonist at concentrations specific for the GluR5 subunit, a reduction
170in excitatory transmission was observed for all neurons studied, in contrast to the 
heterogeneous responses seen in vivo. A paired-pulse protocol was used to determine pre- 
or post synaptic location. In all except one of these recordings an increase in paired-pulse 
ratio was observed following agonist application, strongly suggestive of a pre-synaptic 
location. Activation of GluR5 produced no effect on locally stimulated inhibitory 
responses, precluding an influence on GABAergic transmission in the SSC. However, 
stimulation of excitatory optic tract input could produce both excitatory and inhibitory 
responses in the same cell, indicative of direct excitation via glutamate and indirect 
inhibition via GABAergic intemeurons. The GluR5 agonist reduced both components of 
this response, indicating that GluR5 is likely to be located on presynaptic retinal terminals 
contacting both excitatory projection neurons and inhibitory GABAergic intemeurons.
In conclusion, this study is the first to demonstrate a role of GluR5 in visual processing in 
the rat SSC, and is suggestive of a role of GluR5 in the rat LGN.
17112  Future Work
Future studies in this field should focus on the following objectives.
•  Electron microscopy to confirm the presynaptic location of KARs in the rat SSC.
•  In vivo iontophoresis and single-unit, extracellular recording in the LGN to 
characterise the involvement of KARs in this structure, with subsequent patch 
clamp studies to separate cortical and retinal input.
•  Aspiration of cell contents following patch clamp recording, followed by single-cell 
PCR to confirm and identify the presence of KAR subunits (plus splice variants).
•  HPLC on retinal tissue following intravenous application of LY382884 to 
determine whether the drug crosses the blood retinal barrier.
•  Investigation into cellular mechanisms mediated by GluR5 in the SSC and LGN. 
Metabotropic mechanisms may be examined with the use of pertussis toxin (Gi/o 
inhibitor), staurosporine (a PKA/PKC inhibitor), or the more selective calphostin C 
(a PKC inhibitor).  Ion channel involvement may be studied by manipulating Ca2+ 
or K+  concentrations.
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22514  Appendix
Table 2.  Pharmacological compounds used in the research
COMPOUND SPECIFICITY STRUCTURE
AMPA AMPA agonist 0
II
H,NCH,—P—OH 
‘  1  
OH
NMDA NMDA agonist
c h3nh  h 
\
HOOC-CHo-C-COOH
ATPA GluR5 agonist
AP-5 NMDA antagonist 0   0  
OH  NH:
226NBQX AMPA/KAR antagonist
H
LY382884 GluR5 antagonist
„ x r q ± “'
H
227DRUG SPECIFICITY STRUCTURE
GYKI 52466 AMPA antagonist
c o p
Bicuculline GABAa antagonist
O-  r-,  .  »
i.  :  j, o   CH.
!   f  °
0  0
CPPG Group III mGluR antagonist
PO(OKb
HOzC^pNHz
LY393053 Group I & II mGluR antagonist
228CPG55845 GABAb  antagonist
229